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Abstract 
 
Graft contracture of tissue engineered buccal mucosa models has been 
monitored and characterised with Raman Spectroscopy. Tissue engineered 
buccal mucosa grafts have been used clinically for the reconstruction of head 
and neck cancer and for extraoral applications such as replacement of scarred 
tissue in the urethra. However, both in the laboratory and clinically, these 3D 
models exhibit contraction compromising the proper functionality of the 
surrounding tissues. Graft contraction continues to be a poorly understood 
clinical problem and what is needed ideally is a better understanding of the 
underlying biochemical mechanism behind contraction. Since studying collagen 
crosslinking biochemically is technically difficult, assays are tedious and not 
very reliable, Raman spectroscopy was elected as the technique of choice to 
characterise and monitored the process of contraction. In this research project, 
the process of contraction was characterised as a function of time before and 
after incorporation of β-APN drug. The use of multivariate analysis (MVA) 
techniques highlighted the increase of a-helix triple structure as a function of 
time and extent of crosslinking. A reduction of a-helix formation was also 
noticed after incorporation of β-APN drug and inhibition of contraction. 
Together with this, formation of β-sheet structure was also highlighted by the 
statistical analysis after inhibiting crosslinking of collagen fibres. Together with 
this, the amide III region was also identified as a biomarker for the progression 
of contraction in all three layers of the oral mucosa graft. A turnover of the 
I1335/I1245 cm-1 doublet was noticed as crosslinking increased. No turnover was 
seen after incorporation of β-APN drug into the experiment. This region is 
representative of the peptidic bond of the polypeptide chains. Findings represent 
a stepping stone towards a better understanding behind the nature of this 
process. It opens up the possibility of considering the participation of these 
biomarkers, as a complementary route of collagen cross-linking progression, 
coupled with the important role that lysyl-oxidase (LOX) enzyme plays on it 
during the process of contraction.  
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 1 
1 LITERATURE REVIEW 
 
Due to their versatility, tissue-engineered buccal mucosa grafts have been used 
not only for intraoral applications –to repair cleft palates or for reconstructive 
surgery in head and neck cancer- but also in extraoral applications to replace 
scarred tissue in the urethra. However, when applied clinically in the patient, 
tissue-engineered buccal mucosa grafts exhibit contraction and at some point 
can undergo fibrosis down the line that can lead to incorrect functionality of the 
tissue. These contractions and fibrosis of the oral mucosa graft continue to 
develop after it has been implanted at the injury site, resulting in approximately 
40% of contraction after just 1 month. Recent studies in skin and oral mucosa 
have shown that this contraction might be a result of the cross-linking of 
collagen primarily induced by keratinocytes. To tackle this problem, 
pharmaceutical agents have been applied to oral mucosa grafts in order to reduce 
contraction, β-APN being the most common. Although, while it may be true that 
these drugs can significantly reduce the extent of contraction, their biochemical 
pathway and interaction with the collagen cross-linking remains unclear. 
Having a clear understanding of the mechanism behind contraction at the 
cellular level and the effects of potential drug candidates to reduce this 
phenomenon is of upmost importance. Currently, there is no method available 
to accurately measure the crosslinking of collagen at the biochemical level, as 
conventional assays are tedious and not very reliable 
(Electrochemiluminescence ECLIA to indirectly measured collagen synthesis 
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through the concentration of amino terminal propeptide of type I (P1NP), and 
Sircol soluble collagen assay). Raman spectroscopy offers a feasible alternative 
to overcome these limitations. This technique has already established a spectral 
profile of particular bonds in the collagen molecule. Therefore, it can easily 
identify biochemical differences occurring in the collagen molecule at different 
stages of contraction. The use of vibrational spectroscopy would be of great help 
when analysing the different degrees of contraction in order to establish a 
database of the natural phenomenon of contraction. Once this is done, it would 
be interesting to analyse the biochemical pathway and interaction of β-APN 
with collagen molecules and to relate each spectral profile to the different 
extents of contraction. 
 
1.1 ORAL MUCOSA 
The oral mucosa is a tissue of the mucous membrane family. In general, the 
mucous membrane is a moist tissue lining all cavities within the human body. 
In the oral cavity, this moisture mucous lining is also known as oral mucosa and 
is responsible for protecting all internal tissues inside the mouth by acting as a 
barrier and preventing them from being exposed to the exterior environment.1 
 
Oral mucosa is formed of two main layers, (i) the oral epithelium and (ii) the 
lamina propia or connective tissue. According to the region, oral mucosa can be 
connected or adhered to deeper structures through a loose connective tissue 
known as the submucosa.2 These three layers of the oral mucosa closely 
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resemble the anatomy of skin, where the oral epithelium corresponds to the 
epidermis, the lamina propia to the dermal layer and the submucosa to the 
hypodermis.  
 
While it may be true that the oral mucosa is mainly formed of three general 
layers, this lining membrane also exhibits some histological alterations 
depending upon its location within the oral cavity. For instance, the oral mucosa 
that lines both maxillaries is known as the masticatory mucosa. Exposure to 
continuous friction due to chewing forces stimulates the mucosa to develop 
structural variations in order to withstand these mechanical forces.3 Thus, a 
keratinised layer on the uppermost layer of the oral epithelium is formed.   
 
On the other hand, lining mucosa is barely exposed to mechanical forces, thus 
being characterised by a non-keratinised epithelium. Exposure to only mild 
forces makes this type of mucosa more flexible and distensible, rendering it 
easier to adjust to any movement caused by deeper structures. Since the lining 
mucosa is found to be covering everywhere else apart from the masticatory and 
specialised region, it represents 60% of the oral mucosa within the oral cavity.1 
Therefore, this is the type of oral mucosa that will be further discussed in this 
report.  
 
1.1.1 ORAL EPITHELIUM 
Non-keratinised oral epithelium is the outermost tissue and the first barrier 
against the oral environment. As every tissue, the oral epithelium is formed by 
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a group of cells working in a coordinated manner and organised in four different 
layers: 
 
Stratum basale layer is the boundary between the lamina propia and the 
epithelium layers. It is formed by cuboidal squamous epithelial cells tightly 
packed and uniformly distributed along the basement membrane, attaching to 
the latter one by a link between hemidesmosomes and laminins. Usually one to 
two cells thick, keratinocytes in this layer originate from a stem cell population 
that have a high proliferative capacity. When keratinocytes are meant to 
differentiate, a transformation in their anatomical structure takes place, resulting 
in the detachment of their hemidesmosomes, the ending of their cell division 
capacity and thus their migration to the outermost layers.4 
 
Stratum spinosum layer is formed by all keratinocytes that have migrated 
towards the uppermost layers. Usually a few cells thick and adopting a spinous 
morphology, these cells start exhibiting a significant eosinophilic cytoplasm and 
a considerable reduction of their nucleus as they start progressing to the 
outermost layers.5 
 
Intermediate layer is where cell’s morphology is no longer spinous, and they 
lack the capacity for producing keratin. Keratohyaline granules are hardly 
present and keratin filaments are randomly distributed in between the epithelial 
cells. By forming a network within the intermediate layer, keratin filaments 
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anchor to desmosomes keeping cells closely attached side-by-side and hence 
transmitting tensile strength to the epithelium.  
 
Superficial layer is the uppermost layer of the non-keratinised epithelium. 
Lacking stratum granulosm and stratum corneum, the superficial layer allows 
the epithelium to be pliable and able to withstand both shielding and tensile 
forces.6 
 
1.1.2 BASEMENT MEMBRANE  
Also known as the basal lamina, the basement membrane is a corrugated layer 
connecting both the epithelium and lamina propia. The corrugated-like shape 
increases the surface area and leads to the formation of what is known as rete 
ridges. The uppermost region of the lamina propia interlaces between the 
multiple ridges increasing the area of attachment along the epithelium and 
connective tissue.7 Since the epithelium has no capillary vessels, attachment to 
the lamina propia allows the epithelium to receive enough nutrients from the 
bloodstream in order to continue functioning. The basement membrane mainly 
comprises of two parts: 
 
Lamina lucida: the layer where basal cells get attached through 
hemidesmosomes. It also contains a high number of glycoproteins and 
anchoring filaments that go through it trespassing the lamina lucida as opposed 
to hemidesmosomes. 
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Lamina densa: underlies and supports the lamina lucida. It contains loops of 
anchoring fibrils made of collagen type VII, in which collagen type I and III go 
throughout the tissue interlinking to the lamina densa creating a flexible loose 
connection.8 Laminin and collagen type IV are also present in lamina densa. 
 
1.1.3 LAMINA PROPIA: EXTRACELLULAR MATRIX 
All connective tissues are composed of two main components, (i) resident cells 
and an (ii) extracellular matrix (ECM) structure. 
 
Cells living in the connective tissue are responsible for their own synthesis and 
preservation. They ensure their maintenance by producing an ECM structure, 
which mainly consists of different types of secreted proteins working in a highly 
organised and coordinated manner. The ECM is not only produced to give 
structural support to resident cells but also to provide both mechanical and 
biochemical properties to the connective tissue in general.9  
 
 As mentioned before, there are different types of proteins forming the ECM, 
with collagen being the most abundant and main constituent of the connective 
tissue6). As a protein, collagen is a macromolecule comprised of several amino 
acids acting as building blocks to form a polymer chain. Polymerisation of 
amino acids takes place through a condensation reaction resulting in a 
polypeptide chain and a molecule of water as a by-product. The amino group 
(NH2) of amino acid A binds to the carboxyl group (COOH) of amino acid B 
resulting in the formation of an amide bond (O=C-NH), also known as a peptide 
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bond. A protein containing more than three amino acids (i.e. more than three 
peptide bonds) is considered a polypeptide chain.10  
 
This macromolecule is a protein comprising mainly of repetitive proline-rich 
tripeptide domains in which the three main amino acids are glycine, proline and 
hydroxyproline (Gly-X-Y).10 These tripeptide domains then polymerise 
together and form a long polypeptide chain. If this is the case, the C=O group 
of residue A binds to the NH group of the residue C leading to the formation of 
a right-handed helical polypeptide chain Figure 1.  
 
Figure 1. Helical polypeptide chain of collagen type I molecule. The C=O group 
of residue A binds to the NH group of residue C, resulting in the formation of a 
helical polypeptide chain. [This figure has been adapted from Rashid et al.11] 
 
Subsequently, three α-polypeptide chains become wound together forming a 
triple helical structure of collagen resulting in a fibre-like structure. It is this 
fibre-like structure that makes it easy for collagen to produce a highly 
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interconnected network throughout the ECM, contributing to the structural 
integrity and biochemical properties of the connective tissue.12 
 
1.1.3.1 THE COLLAGENOUS DOMAIN 
The term collagenous is assigned to any protein that is composed of a triple 
helical structure derived from three polypeptide chains coiled up together to 
form a right-handed triple helix structure, irrespective of the type of collagen 
molecule.12 
 
Having a glycine residue at every third position along the polypeptide chain is 
the main prerequisite for this helix structure to be formed.9 Glycine is the 
smallest amino acid; its side group is only formed by a hydrogen atom, which 
occupies little to no space when compared to the side groups of other amino 
acids. Hence, glycine residues are positioned towards the centre of the triple 
helix, placing the bulkier side groups on the outside and thus keeping the 
structure tightly packed around a central axis.10 
 
In order to stabilise the triple helical molecule, different amino acids, such as, 
proline or lysine can undergo hydroxylation due to enzymatic activity.9 Derived 
amino acids like hydroxyproline and hydroxylysine can then make 
intramolecular bonds with the hydrogen atom of glycine resulting in a 
chemically bonded triple helical molecule.10 Collagen molecules can measure 
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approximately 1.5 nm in diameter and around 300 nm in length, containing 
around 1000 amino acids in total.13 
 
Finally, it should be noted that while it may be true that all collagen molecules 
contain at least one collagenous domain within its structure, non-collagenous 
motifs also play an important role in the conformation of each molecule. Thus, 
every collagen molecule is mainly composed of both collagenous (COL) and 
non-collagenous (NC) domains. 
 
1.1.3.2 THE NON-COLLAGENOUS DOMAIN. 
Apart from the triple-helix structure, a collagen molecule will also contain non-
collagenous domains, which also play an important role in the structural 
properties of tissues. The C-propeptide region, for instance, is the non-
collagenous domain located at one end of the triple helical structure. It is known 
as NC1 and strongly induces the formation of the triple helix structure.13 At the 
other end, the N-propeptide domain, also referred as NC2, is responsible for 
regulating the fibril diameters. When synthesising a collagen molecule, these 
non-collagenous domains are part of the procollagen structure, a precursor of 
the collagen molecule. However, to convert procollagen into a mature and 
functional collagen molecule, proteolytical cleavage of both C- and N- 
propeptide sections are required to take place. This cleavage leads to the 
formation of non-collagenous domains at both ends of the triple-helical structure 
that are referred to as C- and N- telopeptides.13 
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Figure 2. Extensions at the end of the collagenous region play an important role 
in facilitating collagen molecules to stagger together to produce a collagen fibril 
since they chemically crosslink and can bind to other molecules.13 
 
As mentioned in the previous section, a collagen molecule is composed of both 
COL and NC domains. Biomechanical properties and classification of collagen 
molecules are dependent upon both the length and quantity of these domains.14 
For instance, collagen type I, II and III all contain a long triple helical region 
with short NC domains at both ends. Due to their standard structure, they tend 
to form collagen fibrils that range between 10 to several hundred nanometres in 
diameter, causing them to be classified as fibril-forming collagens.15 In contrast, 
collagen IV and VII both contain a short triple helical structure interrupted by 
NC domains, where different molecules link together forming a network 
structure.16 These particular features allocate both collagen IV and VII in the 
network formation group.13 
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To date, 26 different types of collagen have been identified and classified into 
different groups depending on their supramolecular organisation and main 
structure.16 Some of the more common classification groups for collagen are 
fibril-forming, fibrillar-associated with interrupted triple-helix (FACITs), 
basement membrane and finally network-forming collagens. Fibril-forming 
collagens comprise collagen types I, II, III, V and XI. They generally measure 
between 10 to 300 nm in diameter and are produced by the connection of 
multiple collagen molecules in a specific ‘quarter stagger’ structure.17,18 More 
specifically, they exhibit a specific striation feature every 67 nm as one-quarter 
of each molecule is overlapped and staggered into another collagen molecule 
from a different row, as illustrated in Figure 3. Collagen fibrils can also 
assemble between one another to produce a collagen fibre, which is a few 
micrometres in diameter. Collagen type I and III are usually found together in 
several different tissues such as skin, cornea and lamina propia of the oral 
mucosa.13 
 
The basement membrane collagen group consists of collagen type IV and VII. 
When compared to the fibrillar forming collagen, collagen IV and VII are 
significantly longer in length. They exhibit a few discontinuities within the COL 
domain, which leads to the formation of NC domains instead. However, in these 
two types of collagens, the N-terminal extension is referred as 7S domains while 
the C-terminal extension is referred to as NC1 domains. Both regions strongly 
induce crosslinking of different molecules. Collagen type IV and VII are usually 
found together in the basement membrane of the oral mucosa and skin forming 
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a network structure. In fact, collagen type IV links with three other molecules 
through their 7S domains, meaning that the crosslinking of multiple 
tropocollagens is possible through disulphide bonds.19 
 
 
Figure 3. A schematic representation of the structure of fibre-like structure of 
collagen type c I across length scales. Three different structures towards the 
formation of a collagen fibre [This figure has been adapted from Caneló et al.20]. 
 
While it is true that several techniques exist that can characterise collagen 
molecule, only a few can analyse the molecular alterations in collagen. It is also 
true that these techniques require a labelling agent and are destructive to the 
sample being analysed. Raman spectroscopy is a label-free and non-invasive 
technique that can probe into the sample and interact with the molecules, which 
allows for specific information about the sample integrity.21 Further, this 
spectroscopic technique allows the analysis of molecules in an aqueous solution, 
significantly broadening the applicability of Raman to a wide range of samples. 
Collagen 
Molecule
Collagen 
Fibril
Collagen 
Fibre
Approx 300 nm
D-spacing around 67 nm
~10 to several 
hundred nm
~1.5 nm
 
~10 µm
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The aforementioned characteristic is unique in the sense that it gives Raman 
spectroscopy more of an advantage over Fourier-Transform Infrared (FTIR) and 
other spectroscopic techniques, which cannot analyse samples in an aqueous 
solution. Plus, there are certain vibrational modes that are active and detectable 
with Raman spectroscopy but not with FTIR. This only applies for symmetrical 
molecules, which can go through a change in polarizability but will lack the 
presence of a dipole since the vibration is symmetric around the central atom.22 
Therefore, Raman spectroscopy has been widely used to characterise different 
types of collagen structures. Some studies have used pure collagen, more 
specifically collagen type I, IV23 and VII24, to establish a spectral profile that is 
unique to each molecule. Other studies have analysed biochemical changes in 
collagen molecules from different sites of the human body including collagen 
modification in eyes25, breasts26-27, lungs28, skin29 and epithelium.30 However, 
with respect to collagen crosslinking there is little known about utilising Raman 
spectroscopy to analyse this in soft tissues. Crosslinking of collagen fibres 
occurs during wound contraction as a normal physiological phenomenon during 
the wound healing process. It is believed that wound healing process plays a 
role in contraction of both skin and oral mucosa in vitro models, which is why 
a comprehensive description of the whole process is described below.  
 
1.2 WOUND HEALING 
Injury of soft tissue is often comprised of (i) cell death at the injury site, (ii) loss 
of the extracellular matrix integrity and (iii) disruption of blood vessels 
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continuity.10 These three scenarios lead to the formation of a wound, which in 
response the body activates a set of different biochemical stages that represents 
an overall of the wound healing process. These interdependent phases work in 
a coordinated manner and overlap in time resulting in the formation of new 
tissue and hence wound closure. 
 
Within the wound healing process there are different stages that can be 
explained individually for an easier understanding, and can refer to in Figure 4 
and Figure 5. 
Haemostasis Stage. When blood vessels are damaged, blood coagulation 
process is initiated as a defensive mechanism and so platelets will transport to 
the wound through the circulatory system. A blood clot, made of fibrin and 
blood cells is formed at the injury site to (i) protect the wound site from the 
exterior and (ii) act as a temporary matrix network so cells can adhere and 
migrate through it.10 At the same time, platelets will induce migration of 
inflammatory leukocytes by releasing both transforming growth factor-beta 
(TGF-b) and platelet-derived growth factor (PDGF).31,32 These two chemical 
mediators not only act as chemo attractants but also as mitogens and motogens 
to induce tissue-specific cells reproduction and proliferation, respectively.33,10 
 
Inflammatory Stage. While platelets continue to release many other growth 
factors, migration of leukocytes to the injury site initiates the inflammatory 
stage. Neutrophils and macrophages remove the remnants of damaged tissue 
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from the wound site -including dead cells, cellular debris and any other foreign 
particle such as bacteria- by phagocytosis.  
 
Apart from cleaning the injury site, leukocytes play an important role in 
promoting cell proliferation. Macrophages for instance, attract fibroblast to the 
wound site by the released of specific growth factors such as PDGF and 
fibroblast growth factor (FGF) (both known to be not only chemo attractants but 
also mitogens of fibroblast cells).10,34 Additionally, neutrophils attract tumour 
necrosis factor (TNF) and monocytes by releasing specific chemical mediators 
such as cytokines (e.g. interleukin-1). Thus, by providing chemical stimuli at 
the injury site, the cell proliferation stage gets initiated. 
 
Cell Proliferation Stage. With new cells invading the injury site, a significant 
amount of growth factors are released by different cells in a simultaneously 
manner. To balance the excess of chemical mediators at the injury site, 
proteolytic proteins eliminate growth factors that were initially released by 
platelets at this stage of the wound healing process. Hence, the remaining 
growth factors being an important part of the cell proliferation stage are (i) FGF, 
(ii) insulin-like growth factor (IGF), (iii) epidermal growth factor (EGF), and 
(iv) vascular endothelial growth factor (VEGF).10 
 
Since chemical mediators induce cell migration and proliferation to the injury 
site, they are known to be the way of communication between cells and their 
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external environment. Chemical signals from growth factors and cytokines 
interact with the cell resulting in the manifestation of receptors at the cell 
membrane.34 These cell adhesion molecules or so-called receptors, are usually 
proteins playing an essential role in cell migration as they served as a link 
between the cells and their surroundings. Integrins is one of the most important 
proteins when referring to cell migration.  
 
As mentioned before, the wound healing process as well as any other 
mechanism within the human body are a series of coordinated processes that 
work in a highly organized manner. When cells need to attach to the fibrin and 
fibronectin network, the adhesive domains within this mesh are upregulated 
rendering easier for integrins -located at the cell membrane- to attach 35. Hence, 
one extreme of the integrin molecule is linked to the fibrin domain while the 
other extreme is connected to the interior of the cell. A balanced adhesion-
strength is ideal as a weak adhesion to matrix proteins would not withstand 
forces caused by cells during migratory movement and a strong adhesion might 
impede migration of cells through the fibrin mesh.36 To facilitate migration of 
cells even more, different proteases such as MMPs, collagenase and serum-
derived plasmin are abundant at the wound site, in particular wound edges. 
Attachment of proteases to cell-membrane receptors allows cells to pass through 
the fibrin mesh by cleaving the protein-based structures.35  
 
	INTRODUCTION & 
LITERATURE REVIEW 
 
 17 
Production of ECM. The formation of the ECM is a controlled process 
regulated by both (i) extracellular matrix cells and (ii) growth factors. For 
instance, while remnants of matrix proteins are being cleaved by specific 
proteases, cells at wound edges are replacing them with new matrix proteins. 
However, in order for cells to reach the centre of the wound, EGF is released to 
stimulate the fabrication of fibronectin.37 Once the adhesive protein is 
synthesised all over the injury site, cells start migrating inward for wound 
closure. When fibroblasts interact with a TGF-b, synthesis of 
glycosaminoglycan, collagen and fibronectin take place. The production of 
extracellular matrix proteins leads to an accumulation of collagen from the edge 
of the wound inward.10,34 
 
Neovascularization Stage. As expected from any living organism, cells need 
oxygen and nutrients to properly function. Hence, vascularisation supply to the 
newly formed extracellular matrix wound bed is up most important. A 
significant amount of cells and growth factors are concentrated in the 
extracellular matrix milieu. In a hypoxic atmosphere, macrophages and 
endothelial cells produce both FGF and VEGF’s.38 Release of these specific 
chemical mediators enhances the synthesis of new capillaries into the newly 
formed ECM wound bed. Once the wound site is all covered with new tissue, 
angiogenesis stage is concluded. 
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Granulation Tissue Stage. In conjunction with cells and extracellular matrix 
milieu, neovascularization of the wound site gives the injury site a pink granular 
appearance. As a result to the formation of new capillaries, cell activity as well 
as other components such as proteins are significantly increased. Proteoglycans, 
collagens and many other growth factors are expressed at this stage of the wound 
healing process. Towards the end of the granulation process, wound contraction 
occurs due to compression of the ECM. While it may be true that the mechanism 
behind this situation remains unclear, it has been established that fibroblast 
develop a myofibroblast phenotype with integrin receptors on their 
membranes.39 By binding to matrix proteins like collagen, the actin-rich 
cytoskeleton of these cells exerts a contractile force to pull the collagen fibres 
together leading to wound contraction.36 
 
Remodelling Stage. Once myofibroblasts have forced a connection between 
themselves, margins of the wound site are finally drawn together. 
Myofibroblasts are no longer needed after wound contraction and thus, 
apoptosis of these cells occurs resulting in the initiation of remodelling phase 40  
 
At this stage during the wound healing process, a significant amount of collagen 
fibres, among other proteins, are accumulated at the granulation tissue. As part 
of the remodelling stage, collagen fibres arrangement is altered in different 
ways. For instance, regulation of collagen synthesis and collagen degradation 
takes place, allowing the organism to produce as many collagen fibres 
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(specialised to each tissue) as needed.38 MMP’s are the proteolytic enzymes 
responsible for collagen degradation at the wound site. 
 
One of the mechanisms of wound healing is for the edges of the wound to try to 
close in what has been described as a purse string effect. In loose skinned 
animals like cats and dogs this skin slides over the underlying fat and muscle 
and this works very well to rapidly reduce the area of the wound. However 
human skin anatomy is different than the anatomy from animal skin, and in 
humans’ skin is connected to the underlying connective tissue and muscle. 
Accordingly, the same mechanism contraction pulls on the underlying tissues. 
This is seen to the greatest extent when skin grafts are used to restore barrier 
function in badly burned patients. These grafts quite often contract and fibrose 
to the extent that they can severely limit joint movement if grafts are placed over 
joints. This loss in mobility as well as the poor aesthetic outcome can quite often 
result in later secondary reconstructive surgery. While a significant amount of 
research has been devoted to this phenomenon, a better understanding of the 
biochemical pathway of contraction in soft tissue remains unclear
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Figure 4. Wound healing stages, including important cells, growth factors and pro-inflammatory cytokines participating in the process.41,42,31  
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Figure 5. Sequential representation of the stages involved wound healing.35,41 
 
This literature review looks at a compilation of studies where Raman 
spectroscopy has been widely used to study the molecular alterations of collagen 
found in soft and hard tissues. This technique has been used to study collagen 
crosslinking as part of the mineralisation process of bone. 
 
1.3 RAMAN SPECTROSCOPY: THEORY AND PRINCIPLES 
A photon can be defined as the quantum of light. In Latin, “quantum” means the 
smallest amount of physical energy that can stand independently as a unit of 
matter. Therefore, a photon is the fundamental unit of energy conforming light. 
 
The natural essence of light, as a form of electromagnetic radiation, is to travel 
throughout space in form of electromagnetic waves. These waves keep a 
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constant distance between each other’s crest and this distance is known as the 
wavelength and it is measured in nanometers (nm). The longer the distance 
between each crest the longer the wavelength and thus, the lower the frequency. 
 
There are several sources emitting energy towards the space. However, each of 
these sources will emit electromagnetic radiation at a specific constant 
wavelength. For instance, visible light will always travel within a wavelength 
range of 400 to 700 nm, whereas X-rays will travel in a wavelength between 0.1 
and 10 nm. The different sources of electromagnetic radiation and their 
corresponding wavelength conforms the wide range of what it is known as the 
spectrum of light. 
 
RS is a technique that employs monochromatic light within the visible range 
(400 to 700 nm) of the electromagnetic spectrum.43 This means that the 
wavelength and frequency of the electromagnetic source remains constant while 
shooting a monochromatic incident laser beam towards the sample. After 
interacting with the sample, radiation can induce the vibration of chemical 
bonds that will be expressed as single peaks in the Raman spectrum.44 Peaks 
will reflect in different ways according to the type of vibration taking place. A 
chemical bond can vibrate in six different ways: symmetric and asymmetric 
stretching, rocking, twisting, scissoring and wagging. 
 
When in room temperature, almost all electrons from the molecules are found 
to be in their lowest energy state,22 this lowest point of energy within the 
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electron cloud is also known as ground state. When the incident beam is 
shooting towards the sample, photons will interact with molecules making 
electrons go from the ground state to a higher level of energy. During this 
interaction between energy and electrons three possible outcomes can take 
place, according to Figure 6. 
 
 
Figure 6. Schematic Representation of the Scattering Outcomes in RS.  
(Adapted from Colthup et al. 1990) 
 
If the electron goes back to its original state, the photon will transfer back into 
the laser beam and thus the wavelength and frequency of the scattered beam will 
remain the same as in the incident beam. This is known as the Rayleigh effect 
or elastic scattering.44 Since only one in one billion photons interacts with the 
electron cloud of the molecule, most photons have no impact on the energy 
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levels of electrons making this effect the most common outcome.45 This can be 
understood as follow: 
 
Rayleigh Effect: 
V Incident beam = V Scattered beam 
 
Since the electron is such a light particle, the interaction between the photon and 
the electron in the molecule is quite subtle. Still if the photon has an impact in 
the energy state of the electron, the scattered beam will have a notorious gain or 
loss of energy that will immediately reflect in a change of both frequency and 
wavelength of the scattered radiation, leading to a subtle change in colour of the 
scattered laser beam.45 This phenomenon is known as Raman shift or inelastic 
radiation, which pertains to the difference in energy between the scattered and 
the incident beam as a result to the gain or loss of energy in the electron 44. It 
can be understood as follow: 
 
Raman Effect:  
V Incident beam ≠ V Scattered beam 
 
This effect comprises two remaining possible outcomes. If after interacting with 
the photon, the electron goes down to an energy level lower than that of the 
initial state, a transfer of energy into the scattered photon has occurred.46 The 
scattered beam has more energy now than the incident beam, which will 
immediately reflect in an increased of frequency and thus shorter wavelength 
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leading to a change in colour of the scattered laser beam.44 This is known as 
Anti-Stoke shift or blue shifting and can be represented as follow: 
 
Anti-Stoke Shift: 
Energy Final vibrational level - Energy Initial vibrational level = X Energy transferred 
V Incident beam + X Energy transferred = V Scattered beam > V Incident beam 
 
In the contrary, if when interacting with the electron, the photon transfers energy 
into the molecule, electrons will go down to an energy level higher than the 
ground state. The loss of energy from the scattered beam entails the elongation 
of the wavelength and hence a decrease in frequency. This is known as Stokes 
shift or red shifting44 and can be presented as follow: 
 
Stokes Shift: 
V Incident beam - X Energy transferred = V Scattered beam < V Incident beam 
 
Stoke shifts are way more common than anti-stoke shifts when in room 
temperature since almost all molecules are expected to be in their ground state. 
Therefore, after interacting with the photon, the number of electrons being 
excited to an energy level higher than the ground state is significantly higher.  
 
1.3.1 INSTRUMENTATION 
The most common instrument setup used in Raman spectroscopy is the Charged 
Coupled Device (CCD) based dispersive spectrometer. A schematic 
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representation of this setup is shown in Figure 7. The laser line is directed into 
the spectrometer towards the beam expander increasing its diameter in relation 
to the magnification of the objective being selected. The now expanded beam is 
then reflected off from strategically placed mirrors to an optical filter and from 
there directed towards the sample. Once the incident beam interacts with the 
sample, the scattered radiation is reflected into the spectrometer and is directed 
towards the optical filters.47 As mentioned before, almost all of the scattered 
radiation contains the same frequency and wavelength as in the incident beam. 
Entailing a significantly higher intensity of Rayleigh scatter when compared to 
Raman scatter; as only a small fraction of the scattered radiation pertains to the 
Raman effect. Therefore, it is upmost importance to remove Rayleigh signals 
from the scattered radiation, as high intensities would mask the Raman signal 
in the spectrum rendering it impossible to be analysed. 
 
As part of the instrumentation, Raman spectroscopy utilises two types of filters 
to separate Rayleigh from Raman scattering: 
 
Notch Filter: It separates Rayleigh scattering from Raman scattering by 
absorbing the laser line wavelength. This filter allows all wavelengths (Stokes 
and Anti-Stokes signals) outside the laser line range to pass through towards the 
detector. 
 
Edge Filters: It retains all wavelengths within a specific threshold region, 
including the laser line wavelength. One of the edges might be considerably 
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close to the Rayleigh wavelength. This filter only transmits one type of Raman 
scattering, either Stokes or Anti-Stokes. Stokes signal (longer wavelength) 
requires long band pass filter, and Anti-Stokes signal (shorter wavelength) 
requires a short band pass filter. 
 
 
Figure 7. Schematic Representation of the Theory and Instrumentation of 
Raman Spectroscopy (Adapted from Cornell). 
 
The entire scattered radiation that goes through the filters towards the detector 
reaches what is known as the diffraction grating. As its name says, the 
diffraction grating separates the Raman signal into individual wavelengths 
allocating them into specific grating lines according to the angle they have been 
spread out. These wavelengths get reflected towards the CCD detector. A CCD 
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detector is a two-dimensional array of pixels. Each pixel receives an upcoming 
wavelength according to its specific angle. Same wavelengths will be dispersed 
at the same angle hence detected by the same pixel, which will reflect in 
intensity and position when interpreting a Raman spectrum. 
 
Depending on the application, Rama spectroscopy has a variety of techniques 
or methods that can facilitate the production and collection of data when 
analysing specific hypothesis.48 These technologies can be seen in Table 1, 
together with their most current applications and limitations.  
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Table 1. Comparison of Raman spectroscopy methods and its current 
applications.48,49 
Raman methods Applications Current limitations 
Raman fibre-optic 
probe 
In vivo probes for 
disease detection 
Heterogenous nature of 
tumours. Raman probe can 
only analyse a single area 
of the target tissue, within a 
tumour lesion there will be 
non-uniform areas of 
normal cells, cancerous 
cells and dysplastic cells. If 
the area analysed by the 
probe is not the most 
cancer-developed area, 
there is room for 
misclassification. 
Conventional Raman 
spectroscopy 
Ex vivo and in vitro 
studies 
Low axial resolution 
High background 
Non-expensive 
Simple to use 
Point-line or array imaging 
Confocal Raman 
spectroscopy 
Ex vivo and in vitro 
studies 
It has high axial resolution 
Deep tissue analysis 
<500µm 
Long acquisition times 
Surface Enhanced 
Raman spectroscopy In vitro studies 
It requires biomarkers 
It requires surface 
enhancers 
Long acquisition time 
Heterogenous intensity of 
the signal 
Low background 
Coherent Anti-Stokes 
Raman 
Ex vivo and in vitro 
studies 
High spatial resolution 
Expensive 
Difficult to implements 
Short acquisition time 
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1.4 RAMAN SPECTROSCOPY AND COLLAGEN 
STRUCTURE 
Raman spectroscopy is a vibrational technique that has been used to analyse the 
progress of different cancers. Different stages during the carcinoma process 
have been identified in breast cancer, lung cancer, oral cancer and melanoma, 
etc.. Since this technique has proven good results by detecting spectral 
differences reflecting biochemical changes during a process, it has been widely 
recognised as an efficient monitoring tool. Being non-invasive, label-free and 
real-time technique Raman spectroscopy has also been used to analyse the 
progress of a tissue-engineered oral mucosa in vitro. As there is no need to label 
the 3D model, no external component can influence the biochemical interactions 
within the cells leading to a natural monitoring of the tissue growth. 
 
1.5 SPECTRAL DATA ACQUISITION.   
To exploit the technique to its full potential it is important to recognise and 
consider a number of parameters that can influence the quality and efficiency of 
the spectral data acquisition. Optimising these parameters is ultimately 
dependent on the type of equipment available and the type of answer that the 
spectroscopist is looking for. Sample preparation is the first parameter that 
should be taken into consideration when using Raman spectroscopy. While it 
may be true that little or no sample preparation is required when analysing 
homogeneous materials, this is not the case for samples that have an organic 
nature. Consideration of how the sample must be presented to the equipment is 
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most important. A proper analysis of what the operator is looking for when 
analysing the sample helps shed light on several preparation methods that can 
improve the outcome of the spectra.22 In some instances, challenges like 
intrinsic fluorescence will arise when analysing specific type of samples. 
Fluorophores are molecules that significantly vibrate when they are expose to 
short wavelengths of electromagnetic radiation. In response, most of the 
samples will reflect back emitting light that will travel in longer wavelengths of 
energy. This phenomenon reflects poorly in the spectra and therefore 
corrections are usually needed. In most cases, correcting the fluorescence 
through a mathematical algorithm available in the operating software is the way 
to go. Others have resorted to using the photo-bleaching feature that will disable 
the fluorophores in the sample after prolonged exposure to the laser. Here it is 
important to consider the type of laser being used. Near UV and visible light 
contain a higher amount of energy that will induce a reaction from the 
fluorophores in the sample. It has been reported that in most of the cases, 
switching to longer wavelengths of electromagnetic radiation will minimize 
fluorescence interference in the spectral data acquisition process.50 
 
Another important parameter to consider is the use of appropriate sample 
holders. Dependent upon the type of samples, in this case biological samples, 
there are a few substrates that are most commonly used despite the effect they 
may have on the raw spectral data. Sample holders made of CaF2, MgF2, and 
glass are the most common type used. The first two are ideal substrates when 
analysing samples which are thicker than <20µm. Their reflective peaks at 320 
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and 405 cm-1 can easily be subtracted without compromising the integrity of the 
spectral data. On the other hand, samples with a thickness of ³20µm can be 
analysed using conventional glass substrates rendering them more cost-effective 
than the first two. However, glass slides are reflected in the raw spectra as three 
intense and broad bands spared across the whole spectral range. To avoid 
invading the quality of the data, it is recommended that the axial resolution is 
improved by ensuring adequate tissue thickness. This can be achieved by using 
high N.A. objectives or increasing the thickness of the tissue as indicated 
previously.51 
 
The number of scans used is an important variable in the spectral acquisition 
process. It goes hand in hand with the time exposure and the quality of data.  
 
These parameters are highly dependent upon the sample being analysed. They 
should be adjusted and tailored to each experiment. However, close attention 
should be paid to the integrity of the sample. Longer exposure of samples to the 
incident beam can sometimes increase the temperature of the sample and affect 
its nature and particular characteristics.  
Once spectral data has been produced and collected, handling and proper 
interpretation of the results is up most importance. For this bioinformatics plays 
a role52 and there are a variety of techniques that can be used and have been 
displayed in TABLE 2.   
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Table 2. Strategies and different algorithms commonly used for appropriate analysis of spectral data.48,49 
Approaches on how to do 
analysis of spectral data 
Research question 
being addressed Algorithm characteristics Chemometric MVA technique 
Exploratory analysis of the 
data 
Is there any 
relationship between 
samples? 
No need of prior information. 
Unsupervised methods can be used. 
Principal component analysis (PCA) 
Dendograms 
Self-organising Map (SOM) 
Sample classification 
Can samples be 
classified into different 
groups? 
Requires previous information. Prediction 
of unseen samples for cluster formation. 
Supervised method can be used. 
Requires validation. 
Partial least squares-DA (PLS-DA) 
Support vector machines (SVM) 
Linear discriminant analysis (LDA) 
Quantitative analysis of the 
data 
Can spectral data be 
correlated with specific 
variables? 
A quantitative prediction in previously not 
seen samples is allowed in relation to a 
continuous variable 
PCA 
Principal component regression PCR 
Support vector regression SVR 
Explanatory analysis 
Is there a difference in 
physical or in chemical 
state of the samples? 
Identifies the spectral differences as a 
function of group 
Unsupervised method 
Based on loading vectors: 
PCA,LDA,CA,PCR 
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Table 3. Techniques used for collagen characterisation 
 
Techniques for 
Collagen 
Characterisation 
The sort of 
Information they 
can deliver 
Studies 
Applying 
these 
Techniques 
Limitations 
M
ic
ro
sc
op
y 
Te
ch
ni
qu
es
 
Transmission 
Electron 
Microscopy 
Morphology, 
Topography 
53 54 Sample preparation 
Scanning 
Electron 
Microscopy 
Topography 55 53 56 Requires dehydration 
Atomic Force 
Microscope 
Information of 
Molecular 
topography 
57 58 Specialised equipment 
Sp
ec
tro
sc
op
ic
 T
ec
hn
iq
ue
s 
Circular 
Dichroism 
Secondary  
and 
 tertiary structure 
59 60 61 
Deconvolution is 
tedious due to 
software 
limitations 
Mass 
Spectroscopy Mass 
62 63 64 
Specialised 
equipment for 
information about 
mass range 
FTIR 
Spectroscopy 
Biochemical 
information 
65 
High absorption of 
water compromises 
quality of signals 
Raman 
Spectroscopy 
Biochemical 
information 
66 
Intensity of 
fluorescence 
compromises 
quality of signals 
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1.6 CHARACTERISATION OF COLLAGEN MOLECULES 
USING RAMAN SPECTROSCOPY 
Raman spectroscopy is highly sensitive mainly to two different secondary 
structures within the collagen macromolecule: the ! -helix and the " -sheet 
structure.67 A secondary structure reveals information on how polypeptide 
chains are being folded, resulting in the formation of any of the above-
mentioned structures. A single polypeptide chain that contains the glycine-X-Y 
motif mainly forms the !-helix structure (abundant in collagen type I and III). 
To stabilise this structure, hydrogen bonding occurs between the –NH group of 
one residue and the C=O group of another amino acid within the same chain. 
On the contrary, multi-stranded polypeptide chains that can be arranged in a 
parallel or antiparallel direction mainly form a β-sheet secondary structure 
(abundant in collagen type IV and VII). This structure is stabilised by cross-
strand hydrogen bonding between the C=O group of one strand and the –NH 
group of another strand.67 It is only logical to expect more variations in the β-
sheet structure than in the !-helix structure,68 as collagen fibrils are unique in 
the presence of the secondary structure. Generally, these secondary structures 
provide both stability and structure to the collagen fibrils. In Raman 
spectroscopy, the frequency of the Amide I and Amide III bands can usually 
detect differences in secondary structures. This region along with lipids and 
proline and hydroxyproline regions are the three main regions frequently 
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involved in the conformational changes of collagen structure Figure 8,Table 4. 
Based on an algorithm on the secondary structure of collagen molecule 
developed by Chou and Fasman,69 19% of the polypeptide chain represents a "-
sheet conformation and 18% represents an ! -helix structure, which is in 
accordance with McColl et al..67 
 
 
 
Figure 8. Raman spectra of collagen structure, an average of 60 spectra. The 
three main spectral regions that frequently reflect main peaks involved in 
conformational changes. 
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Table 4. Main spectral peaks that reflect conformational changes in collagen 
structure. 
 
 
Furthermore, these structures reflect an Amide I band at 1672 and 1650 cm-1, 
respectively,72,67 This correlates with the findings of Kreplak et al. who reported 
an Amide I band at 1655 cm-1 that indicated the presence of an !-helix structure, 
a shoulder at 1630 cm-1 and a 1675 cm-1 peak related to the "-sheet structure.73 
 Raman shift Assignment Reference 
Li
pi
ds
 
2939 C-H vibration 27 
2882 CH2 asymmetric stretching 27 
2849 CH2 symmetric stretching                                   27 
2722 C-H stretching vibration 27 
Am
id
es
 I,
 II
, I
II 
1669 C=O stretching of amide bond (peptide bond)  2770 
1450 NH2 deformation of amide bond (peptide bond)  2770 
1340 CH2 scissoring 2770 
1319 CH3, CH2 twisting 2770 
1271 N-H deformation of amide bond (peptide bond)  2770 
1245 C-N stretching of amide bond (peptide bond)  2770 
Pr
ol
in
e 
& 
Hy
dr
ox
yp
ro
lin
e 936 C-C stretching of protein backbone 2771 
922 C-C stretching of Pro/Hypro ring 2771 
855 C-C stretching of Pro/Hypro ring 2771 
817 C-C stretching of protein backbone 2771 
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Kreplak et al. employed, for the first time, the characterisation of collagen I 
fibrils from an in vitro rat-tail model using surface-sensitive Raman 
spectroscopy (SERS). Although the conformational order of a collagen 
molecule had already been well established, the presence and prevalence of 
aromatic side chains for this protein was a topic that remained unclear. 
Therefore, silver (Ag) and gold (Au) nanoparticles were attached to collagen 
fibres in order to enhance the Raman signal of the samples. Findings showed 
that Raman spectra were quite sensitive to the exposure of aromatic side chains 
on the fibril’s surface. Residues in the helical structure of collagen were 
reflected at 1000 cm-1 for phenylalanine (Phe) and 1605 cm-1 for both 
phenylalanine and tyrosine (Tyr). Additionally, Amide I and III were reflected 
at 1655 cm-1 and 1268 cm-1, respectively. Deformations of CH3 and CH2 were 
reflected at 2933 and 1447 cm-1 while the stretching vibration of NH appeared 
at 3320 cm-1. It was also noted that Au nanoparticles enhanced the Raman signal 
by 105 whereas Ag particles enhanced the signal by 104. The peaks presented in 
this study were the Amide bands, COO- groups and CH vibrations. Finally, the 
Amide I peak also reflected a shoulder at 1630 cm-1, characteristic of a triple-
helix secondary structure.74  
 
Collagen type I represents almost 90% of all collagen in the dermal layers of 
skin and is mainly responsible for providing tensile strength to the soft tissue. 
Skin is also composed of 10% of collagen type IV that is located primarily in 
the basement membrane of the epithelium layer. Due to its structural 
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conformation, this type of collagen is responsible for maintaining the stability 
and integrity of this layer. However, since it represents such a small percentage 
of the total collagen present in soft tissue, it has not drawn much attention from 
the spectroscopic field. Nguyen et al. were the first to characterise collagen type 
IV with Raman spectroscopy. They used conventional Raman spectroscopy to 
characterise the molecular conformation of both collagen type I and IV with 
their respective spectral profile.23 While comparing collagen type I with 
collagen type IV, Nguyen et al. reported that the Raman spectral differences 
reside in both the intensities and the frequency of the bands.  
 
For instance, Amide I, Amide III, and spectral bands 856, 875, 920 and 938 cm-
1 reflected a higher intensity in collagen type IV than for collagen type I. This 
observation was also seen in the 1004 and 1033 cm-1 peaks that corresponded to 
the phenylalanine ring vibrations. With respect to the phenylalanine intensities, 
these differences might indicate a lower content of phenylalanine in collagen 
type I when compared to type IV. It could also suggest that a different structural 
arrangement could exist between both proteins at the level of the phenylalanine 
residues.23  
 
Moreover, the localised difference in the intensity ratio of the Amide III bands 
I1271/I1246 indicated a difference between both proteins in the distribution of 
proline amino acids. This corresponds to the observation that I1246 indicates the 
presence of proline rich regions whereas the I1271 suggests proline poor regions 
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75. Furthermore, the reflectance of Amide I at 1668 and 1673 cm-1 clearly 
indicates a different distribution of the X and Y residues when comparing 
collagen type I to collagen type IV, respectively. Raman spectra also identified 
spectral peaks characteristic of the collagen type IV molecule. Well-defined 
peaks in the 510 and 540 cm-1 bands (S-S vibration) were indicative of the 
presence of disulphide bridges.76 It is also believed that the band at 815 cm-1, 
with higher intensity in collagen I than in collagen IV, may indicate the presence 
of glucosyl-galactosyl-hydroxylysyl in or on leucine crosslinks occurring in 
tropocollagens.77 This feature correlates with the triple-helical structure of the 
collagen type I. Complementary to this, the epidermis, dermis and dermal-
epidermal-junction (DEJ) were also analysed, and their spectral profiles were 
compared in order to decipher the main differences. When skin was analysed, 
this 815 cm-1 band was visible in the dermal layer but not in the epithelium layer 
which correlates with the fact that the dermal layer is mainly composed of 
collagen type I. 
 
1.7 STUDIES OF COLLAGEN CHANGES DUE TO 
PHYSIOLOGICAL PROCESSES  
There are many factors that can damage collagen structure. Collagen is a protein 
that is affected by different physiological processes such as, chronological 
aging, enzymatic reactions, wound healing and many other processes that have 
been listed in Table 5. During chronological aging for example, degradation of 
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collagen type I occurs, which is why the proportion of collagen type I is reduced 
and appears more widely spread over the dermal layers. Additionally, the 
amount of collagen type IV also gets degraded.23  Dermal collagen plays a 
crucial role in repairing and/or regenerating the existing tissue maintaining 
tissue integrity and thus keeping physiological processes on track. However, 
factors such as age, UV exposure and disease have been proven to affect certain 
properties of the collagen molecule.78-79 However, what is occurring at the 
biochemical level of this molecule remained unclear,80 thus requiring further 
work. To understand in more detail the progression of a disease mainly due to 
changes in the collagen structure, a technique that can identify subtle alterations 
is very much needed. Raman spectroscopy can easily pick up on the 
conformational changes of the secondary structure and hydrogen bonding of 
collagen for example. These changes are reflected in the shift of frequency 
positions and width of both Amide I and Amide II bands.80 Dehring et al. for 
example, used the Amide III region as a biomarker to measure collagen damage 
as a function of time. They reported that the Amide III region at 1235 cm-1 
represented the bending vibration of NH2 in a random coil and the peak at 1265 
cm-1 indicated the bending vibration of NH2 in an α–helix structure. In their 
work they used these two band areas to calculate the area ratio of the amide III 
region and they reported that the older the specimen in question the higher the 
area ratio of the Amide III region, indicating a higher content of disordered 
collagen fibres.25 This was seen in the collagen of both a 20-month-old wild 
type mouse and a 12 to 14 months transgenic mouse, when compared to a 
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standard 12 to 14 months wild type specimen. Additional to this, changes in the 
secondary structure of collagen proteins are readily detected by Raman 
spectroscopy. Irrespective of whether these changes are caused by a mechanical, 
environmental or chemical factor, they will be reflected in a shift of band 
position. 
 
In another study, Dehring et al.25 explained the aging process as a chemical 
factor that caused the crosslinking of collagen fibres resulting in an increase in 
a disordered secondary structure in the protein molecule. This is in agreement 
with the shifts to higher wavenumbers seen in both the 20-month wild type at 
1235 cm-1 and the transgenic mouse at 1236 cm-1, when compared to the 
standard 12 to 14-month wild type at 1231 cm-1 band. These changes in band 
position due to structural changes in the secondary structure of the collagen 
molecule are in agreement with the spectral data reported by Zhang et al.,80 who 
suggested that changes in collagen behaviour might be related to collagen 
hydration. It was also believed that as age increases, so does the content of bulk 
water in soft tissues whereas the content of collagen-bound water decreases. 
However, while there have been studies focused on measuring the bulk water 
content of skin tissue, the question of water bound specifically to collagen is 
more challenging to study. 
 
Aiming to characterise spectral features of collagen-bound water, Zhang et al. 
employed confocal Raman microscopy to analyse both collagen type I and intact 
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skin tissue, by using different relative humidity (RH) levels and by recording 
the exchange of H2O to deuterium oxide (D2O).80 They found in both type I 
collagen and skin tissue that the frequency shift of Amide I band goes down as 
the RH value increases. Complementary to this, the frequency shift of Amide 
III band reflected an upshift. 
 
These observations correlate with the well-established theory that when a 
hydrogen atom binds to another atom from a stretching vibration, a downshift 
in frequency is seen, whereas an upshift happens when it involves an atom from 
the bending vibration. However, in the D-H exchange measurements, the Amide 
I band suffered a downshift as the exposure time to D2O kept increasing. The 
1665 to 1657 cm-1 downshift is suggested to be due to the H-D exchange at the 
carbonyl-hydrogen bonding of Amide I. The Amide III band also reflected some 
changes due to the D-H exchange. For instance, a shoulder right next to the 1003 
cm-1 band, on the lower frequency side, was formed along with a decrease in 
intensity of the Amide III band.71 These spectral observations might be a 
consequence of the N-H to N-D exchange. Furthermore, they also reported that 
as RH values kept increasing, so did the intensity of the 938 cm-1 bands. 
 
This observation correlates with the results obtained from the dermis of pig skin. 
This statement is also supported by the findings of Xiao et al.,81 where they 
showed that the intensity of the 938 cm-1 band reduces as the temperature and 
dehydration increases. Furthermore, when Raman analysis of the H-D exchange 
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in both pure collagen type I and pigskin dermis was conducted, it was found that 
the peak intensity at 938 cm-1 decreases as the exposure time to D2O increases. 
These findings correlate with already reported spectral data that the intensity of 
the 938 cm-1 bands can reflect information and keep track of the collagen-bound 
water content in skin tissue.  
 
Collagen I goes through post-translational modifications after a certain period 
of time specifically the hydroxylation of lysine or proline residues as well as the 
glycosylation of hydroxylysine, and here a lysine derivative can be explored.82 
They are usually a by-product of some physiological and pathological 
processes, such as aging and diabetes mellitus.83 The most common 
modification is the non-enzymatic glycation of specific lysine residues within 
the collagen type I molecule. The bonding of a sugar to a lysine residue triggers 
a series of complex chemical rearrangements that lead to the production of 
irreversible advanced glycation end products (AGE’s).84 
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Table 5. Examples of clinical conditions altering the molecular structure of 
collagen. 
 
Clinical  
Conditions 
Compromised 
Tissue 
Studies with Raman 
Spectroscopy 
Ph
ys
io
lo
gi
ca
l C
on
di
tio
ns
 
A
ge
-re
la
te
d 
co
nd
iti
on
s  
Ageing 
Bone 
 Cartilage 
Skin 
Ager et al., 2005 85 
Dehring et al., 2006 25 
Nguyen et al., 2013 86 
Glycosylation  Skin Gilbert et al., 2013 
71 
Pererira et al., 2017 87 
Dehydration Cartilage  Skin Fields et al., 2017 
88 
 Mineralization Bone Paschalis et al., 2001 
89 
Buckley et al., 2012 90 
Pa
th
ol
og
ic
al
 C
on
di
tio
ns
 
W
ou
nd
 c
on
tra
ct
io
n Wound healing 
(wound contraction) Skin 
Zhang et al., 2011 91 
Hao. Liu et al., 2016 92 
Yan et al., 2017 93 
Sun et al., 2018 94 
Skin graft contraction Skin   
 
Glycosylation 
 (disease related, e.g. 
Diabetes Mellitus) 
Skin Guilbert et al., 2013 
71 
Pereira et al., 2015 95 
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These series of modifications and AGE’s immediately reflect upon the 
properties of collagen type I, resulting in a loss of flexibility of the triple-helix 
structure and hence rigidity of the molecule.96 Failure to reduce over 
glycosylation can lead to diseases, such as scurvy and osteogenesis imperfecta 
respectively.97,98  Even though a fluorimetric assay is the most common 
technique employed to quantify the amount of AGE’s present in the glycation 
process,99 the molecular changes occurring during the this process remained 
unclear. Experiments performed in this area aimed to achieve a clearer 
understanding of the physiopathology process of ageing.95 The increasing 
presence of AGE’s in skin during aging or age-related diseases, such as diabetes 
mellitus is well documented.100 M. Guilbert et al. used Raman 
microspectroscopy to characterise native and in vitro-glycated collagen I to 
identify to what extent these post-translational modifications affect structural 
features of collagen. This study showed that the Amide I band remained in the 
same frequency shift as the glycation doses increased. This statement supported 
that no conformational change occurred in the triple-helical structure of collagen 
I during glycation. Additional to this, most of the spectral bands showed an 
increase in intensity as glycation doses increased, except for the 470 cm-1 and 
1556 cm-1 bands. These spectral bands are representative of the proline and 
hydroxyproline/proline rings respectively. The reduction of intensity of these 
bands reflected a clear alteration in the exposure of proline residues within the 
collagen type I molecule upon the glycation process. This experimental design 
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resembled the pathophysiological process of glycation occurring in the human 
body. In fact, the concentration of glucose used in this experiment represented 
the sugar concentration within the bloodstream of, for example, patients with 
severe diabetes mellitus (50 mM).101,102 However, the findings of Pereira et al. 
differ from those of Guilbert et al., Pereira et al.  used confocal Raman 
spectroscopy to characterise the non-enzymatic glycation in skin tissue from 
diabetic elderly women (DEW), healthy elderly women (HEW) and healthy 
young women (HYW). Results indicated the presence of a protein adduct, 
Pentosidine and Glucosepane, which are the main AGE’s responsible for the 
transformation of skin structure.95 These adducts were reflected in the 
proline/hydroxyproline (800-1000 cm-1) and also in the Amide I and Amide III 
region. It is important to mention that the glycation of collagen molecules ends 
up with the formation of AGE’s.103,104 Furthermore, prior to this study, Glenn et 
al. characterised the presence of AGE’s in Bruch’s membrane (of the cornea) 
with confocal Raman microscopy. Raman spectra reflected the presence of 
AGE’s adducts in the extracellular proteins. These findings correlate with the 
study of Sell et al., who verified the same procedure. It is worth mentioning that 
these non-enzymatic AGE’s can follow two paths: the first one by producing 
free radicals, and hence leading to tissue damage; the second one by inducing 
crosslinking of proteins, such as collagen type I, and thus contributing to skin 
damage.95 These structural changes in collagen type I produce a protein 
denaturation and a resistance to degradation, which would normally occur by 
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MMP.105,106 Collagen type I goes through a structural rearrangement resulting 
in the exposure of proline and hydroxyproline amino acids.  
 
As mentioned before, the extracellular matrix in skin is mainly formed of a 
collagen mesh that gives stability and integrity to the soft tissue, and also acts 
as a cytoskeleton structure for cell adhesion. This is why this protein has such 
an important role during wound healing process in skin. When scar formation 
occurs, it is well known that the morphology of scar tissue is significantly 
different to that of normal skin. For a start, collagen fibres in the scar tissue are 
more tightly packed and oriented in a parallel manner. However, the 
morphology of collagen gets more complicated as scars can differ from one 
another.107,108 It has been well documented that formation of collagen fibres 
takes place during the early stages of the wound healing process, which leads to 
the formation of scar tissue. Finding a trace of newly regenerated collagen fibres 
should therefore be possible during the early stages of wound healing. 
Currently, there is a real need to characterise the regeneration of collagen fibres 
during this process in order to establish the most appropriate treatment against 
dysfunctional scar formation. This is important as the formation of extensive 
scar tissue can reduce patient mobility -as in extensive skin graft contractions 
which often follow burn injuries- and obviously it can be cosmetically 
disfiguring. In 2016, Hao Liu et al. used Raman spectroscopy to characterise the 
regeneration and morphology of collagen formation at different time points 
during the wound healing process by calculating the band area ratio of 
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1665/1445 cm-1 bands and monitoring collagen levels present in wound beds. 
The 1665cm-1 band expressing the presence of collagen content through the 
stretching vibration of the carbonyl group v(C=O) or amide I. The 1445cm-1 
band is representing the scissoring vibration of CH2, coming from the total 
matrix of the wound sample. When calculated, the area ratio of these two peaks 
kept increasing as a function of time, indicating that collagen levels were higher 
by the latter stages of the healing process. This method coupled with Principal 
Component Analysis (PCA) indicated a clear separation of groups based on 
different stages of dealing wound healing. However, although an indication of 
collagen levels as a function of time is considered valuable information, an in-
depth description of how secondary structures of this protein are affected during 
the wound healing process is still needed.  
 
The ECM of skin tissue is mainly composed of collagen type I and collagen type 
III. In uninjured skin tissue, the conformational ratio of collagen type I to 
collagen type III is about 85% to 10% respectively. Due to the morphology of 
both types of collagen, collagen type I provides tensile stiffness to the skin while 
collagen type III shows more distensible properties. These properties are the 
main reason why the content of collagen III is higher than collagen I during the 
early stages of the wound healing process.92 In pathological processes such as 
diabetes, the production of collagen is inevitably delayed and so is the healing 
process of any injury. These disturbances result in a delayed re-epithelisation 
due to a defective migration and proliferation of keratinocytes and fibroblasts, 
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giving the appearance of a domino effect. Therefore, treatments to promote 
collagen production and healing particularly in diabetic wounds are needed. Yan 
et al. used Raman microspectroscopy to characterise normal, diabetic and MSC-
treated diabetic wounds at different time points of the wound healing process. 
These experiments were carried out to characterise and validate the use of MSC 
as a treatment for diabetic wounds. With this study they concluded that the band 
area ratio of 1665/1445 cm-1 provides information about collagen accumulation 
at different time points of wound healing process. Using PCA as the analytic 
method, different healing groups clustered according to the ratio of the previous 
bands mentioned. The difference in area ratio allowed for a separation between 
wound samples of different healing time points. These findings indicated that 
the progress of collagen accumulation in wound healing process can be 
monitored by Raman spectroscopy. 
 
1.8 STUDIES OF COLLAGEN CONTRACTION IN SKIN 
AND ORAL MUCOSA GRAFTS  
 
Burn injuries are among the most traumatic injuries across the world and are 
listed as the 4th most common trauma worldwide.109,110 They are considered a 
global public health problem, being responsible for nearly 180,000 deaths per 
year.111 In 2004, ~11 million people worldwide were victims of severe burn 
injuries requiring medical attention,111 and only in the UK, ~13,000 people are 
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admitted in the hospital per year due to burn injuries.112 This traumatic injury is 
considered one of the main leading causes of disability-adjusted life-years 
(DALYs).  
 
In patients with extensive skin loss (due to burn or traumatic injuries in general), 
large areas of skin grafts are the treatment of choice. However, it has been well-
reported that even after implantation of the skin graft to the surface area of a 
wound, contraction of the graft continues to occur. This contraction of the skin 
graft after implantation is an unfortunate event that often results in decreased 
mobility -due to the heavily contracted skin- and very visible skin deformities 
that can seriously affect the patient's confidence particularly in young 
children.113  
 
While a significant amount of research has been devoted to study the contraction 
of skin grafts, a better understanding of the biochemical pathway of contraction 
in soft tissues remains unclear Error! Reference source not found.. During the 
wound healing process, crosslinking of collagen fibres occurs as part of the 
normal physiological phenomenon of wound contraction. While it may be true 
that skin grafting has proven to reduce wound contraction when implanted in 
wounds, they have also shown a degree of contraction that sometimes results in 
joint mobility. This phenomenon is not only seen in skin grafts but unfortunately 
is also present in oral mucosa grafts.  
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Due to its versatility, oral mucosa grafts have been widely used for both intraoral 
and extraoral applications such as repair of cleft palate or reconstructive surgery 
for head and neck cancer and also to repair scarred tissue in the urethra. 
However, both clinically and in the laboratory, this contraction of skin and oral 
mucosa grafts continues to advance while culturing and even after implantation 
at the injury site.  
 
Contraction in a full-thickness TEBM model is a reduction in the surface area 
of the graft with concomitant thickening (i.e. no overall reduction in mass). This 
contraction is most vigorous when the tissue-engineered graft is not properly 
secured. Suturing of the edges massively reduces the extent of the contraction. 
In fact, in 2001, Chakrabarty et al. explored the nature of contraction occurring 
in an in vitro tissue-engineered skin model, as well as different methods to 
reduce or avoid this phenomenon. The thickness of the dermal matrix used, the 
number of keratinocytes and fibroblasts added, and the methodology of 
sterilising the dermis were all examined for their impact on contraction of these 
engineered skin models. One interesting fact was that within a few days of 
contraction, the epidermal keratinocyte layer were removed leading to the 
relaxation of the underlying dermis and thus going back to its pre-contracted 
original thickness and surface area.40 Moreover, it was also noticed that 
increasing the number of keratinocytes seeded increased the degree of 
contraction. This observation was also confirmed when using collagen gels as a 
dermal matrix.114 It was then shown and concluded that fibroblasts had little to 
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no influence over this process. Which led to the hypothesis that contraction of 
these 3D skin models is mainly due to keratinocytes exerting contractile forces 
over the dermal layer,40 irrespective of the sterilisation method used on the de-
epidermised dermis (DED). Not to mention that the methodology of sterilising 
the dermis did affect contraction essentially in a way in which, the stiffer the 
dermis the less they contracted and the softer the dermis the more they 
contracted. 
 
Furthermore, Chakrabarty et al. measured the dermal mass of the DED before 
and after seeding both keratinocytes and fibroblast on the dermal matrix. 
Despite the number of cells being seeded, dermal mass remained constant 
throughout the whole process whereas dermal thickness increased while 
contraction was occurring. This strongly suggested that collagen fibres were not 
being degraded but instead being rearranged in a different way.40 This 
observation goes in agreement with findings from Harrison et al., who used a 
pharmacological approach to identify any possible evidence for collagen 
synthesis, breakdown or rearrangement of collagen fibres.113 Therefore, in order 
to investigate the mechanism behind contraction, pharmacological agents 
targeting collagen crosslinking, synthesis and degradation rates were used and 
their effects related to the degree of contraction observed. Briefly, incorporation 
of vitamin C into the cultured models resulted in a significant increase in 
contraction. At the same token, contraction was significantly reduced when 
culturing these models in low-calcium medium.115 Data from this study also 
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showed how the extent of contraction significantly increased when adding other 
pharmacological agents into the culture medium, such as estrogens (e.g. Estrone 
and 17b-estradiol), MMP-2 and MMP-9 activity. Additionally to this, and in 
order to inhibit the effect that these drugs were having in contraction, 
Chakrabarty et al. experimented with Galardin, a broad-spectrum inhibitor for 
MMP agents; however, it was found to be ineffective in influencing contraction. 
Therefore, based on these studies, it appeared that collagen fibres underwent 
covalent crosslinking to each other over time eventually rendering contraction 
an irreversible process. This is well supported with previous literature stating 
that LOX enzyme promotes the crosslinking of collagen fibres and studies with 
b-APN, a plant-derived agent known to inhibit lysyl oxidase activity, showed 
that contraction could be reduced to a significant degree by inclusion of this 
drug in the tissue-engineered skin model as it was developing.113 
 
Graft contraction continues to be a poorly understood clinical problem and a 
better insight into the underlying biochemical mechanism behind contraction is 
still very much needed.  
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Table 6. Studies on contraction of skin and oral mucosa grafts. 
 
 
 
1.9 STUDIES OF COLLAGEN CHANGES DUE TO 
COLLAGEN MODIFICATION AND PROCESSING.  
Collagen, as previously stated, is present in the extracellular matrix of all tissues 
and provides tissue integrity to enhance its mechanical responsiveness. 
Micromolecular changes occurring in the collagen molecule can have a strong 
impact on the proper function of the tissue. Heart valve leaflets, for example, 
are mainly composed of three different layers: the ventricularis, the spongiosa 
and the fibrosa. The latter layer is mostly formed of collagen and it is responsible 
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for providing stiffness and strength to the leaflets during diastolic movements. 
Degenerative modifications in this layer could easily compromise the 
functionality of the aortic valve. In this scenario and to ensure the proper 
functionality of the heart valve allograft, monitoring the tissue before 
implantation is currently available. However, these techniques only detect 
macroscopic damages, which is why detection of micro-molecular defects is 
still very much needed. Layland et al. utilised Raman spectroscopy to analyse 
conformational changes occurring in aortic valve tissues after cryopreservation 
aiming to identify any structural change or damage as a response to the allograft 
preservation methods. The porcine aortic valve leaflets were exposed to 
collagenase (a degrading enzyme) for different periods of time. The longer the 
leaflets were exposed to the enzyme, the more the spectral intensities were 
reduced. Layland et al. analysed all Raman data with the multivariate analysis 
method (MVA) known as PCA. They found out that the longer the leaflet 
samples were exposed to collagenase, the more separated the groups would be. 
The Raman data of leaflets exposed to collagenase for 17 hours were clearly 
separated from the data belonging to the non-treated samples. This separation 
was more obvious after 17hrs than after 15 min. The bands at 938, 1244, 1272 
and 1664 cm-1 were the peaks considered when comparing these groups. It was 
concluded that the reduction in intensities was related to the degradation of 
collagen. It is also believed that reduction of intensities could be due to collagen 
fibres being less dense when treated with collagenase. 
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Both, excessive and/or insufficient crosslinking of collagen fibres are a serious 
problem that can result in several different diseases (e.g. Fibrosis and ED 
syndrome, respectively). As everything, a balance must be kept for the proper 
functionality of any soft and hard tissue. Without the formation of a collagen 
mesh in the ECM, attachment of cells would not be possible, and tissues would 
lack stability and tissue integrity. At the moment, there are many collagen-based 
biomaterials available for clinical applications but to improve their 
immunogenic and mechanical properties, they have undergone several chemical 
procedures. One of these chemical methods normally involves crosslinking with 
glutaraldehyde (GA).70 While a few authors have investigated the process 
behind the GA and collagen bonding, the chemistry behind this remains 
unclear.123,124 Raman spectroscopy can identify specific biochemical changes 
occurring in a specific molecule. Interactions with other molecules lead to the 
formation of different functional groups that can easily be reflected on the 
Raman spectra. Accordingly, M. Jastrzebska et al. used Raman spectroscopy to 
analyse both (i) Achilles tendon isolated collagen and (ii) glutaraldehyde-
stabilised porcine pericardium to see if Raman spectra could pick up on the 
chemical bonds formed by this glutaraldehyde-collagen mechanism. M. 
Jastrzebska et al. identified four types of chemical bonds in this study, ether-
type bond, amide NH with an aldehyde group, secondary amines through Schiff 
base intermediates and Pyridinium-type cross-links.   
 
Ether groups: 
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These bonds are reflected in Amide I, Amide III, 1094 cm-1 and 1300-1330 cm-
1 spectral regions. The Amide I band reflected a reduction in intensity after 
collagen type I was exposed to glutaraldehyde. This reduction in intensity was 
thought to be due to the formation of an ether type bond between the aldehyde 
group of the GA molecule and the C=O group of the peptidic bond. This reaction 
might need the presence of an H2O molecule in order to take place. Aside from 
the discrepancy in intensity, an upshift of Amide I was also observed after being 
in contact with a GA molecule. In native collagen type I, Amide I and Amide 
III were reflected at 1655 cm-1 and 1247/1269 cm-1 respectively. However, after 
exposure to GA molecule, Amide I was reflected at a frequency of 1664 cm-1 
whereas Amide III was downgraded to 1243/1266 cm-1. It has been well-
documented that when a hydrogen atom is bonded to an atom from a stretching 
vibration, this bond is reflected by a downshift. However, if the hydrogen binds 
to a bending vibration bond it would be reflected as an upshift. The formation 
of an ether type bond at the level of the C=O group gives no space available for 
hydrogen bonding. This theory justifies the findings of an upshift and downshift 
of Amide I and Amide III respectively and indirectly correlates with Zhang et 
al. findings as well. Furthermore, the downshift observed in Amide III bands 
correlate with the findings obtained from Gniadecka et al. work 125. In their 
study, a downshift of the amide III band was properly identified when analysing 
photo-aged skin. This spectral feature was explained as a higher extent of 
protein folding. Other studies have shown that the amount of crosslinks in a 
collagen molecule increased after exposure of skin to UV light 126127128. 
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Another distinct observation between the non-treated and glutaraldehyde-
treated pericardium tissue relies on the intensity of the spectral range of 1300 to 
1330 cm-1. An increment in the intensity band was reported after pericardium 
tissue was exposed to glutaraldehyde. This increase in intensity may be 
reflecting the CH bending from an aldehyde group before the formation of an 
ether type bond. Similar behaviour is observed in the 1094 cm-1 band that is 
expressing the asymmetric stretching vibration of the C-O-C bond. It is only 
logical to assume that since the C-O-C is the functional group of the ether type 
bond, after exposure to the GA molecule, the formation of this bond has 
considerably increased and so does the intensity of the 1094 cm-1 band. 
 
Secondary amides: 
These are observed in spectral ranges of 1266-1272 cm-1 and 3200 to 3700 cm-
1. Within the 1266 to 1272 cm-1 spectral range, the deformation of N-H group 
of the peptidic bond is expected to be reflected. In both collagen and 
pericardium tissue there is a decrease in intensity in the N-H deformation of 
Amide III region. M. Jastrzebska suggested that this spectral feature could be 
explained by the bonding between the carbonyl group C=O from the GA 
molecule to the NH of the peptidic bond of collagen, forming a secondary amide 
type of bond. In fact, this statement also reflects on the decrease in intensity of 
the 3324 cm-1 band, which represents the symmetric vibration of the NH group 
70. 
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Secondary amine groups through Schiff base intermediates:  
It has been well-documented that primary amines (NH2) of both lysine and 
hydroxylysine residues can bind to the aldehyde group of an external molecule 
through the formation of a Schiff base. This statement is supported by the work 
of M. Jastrzebska et al., where the scissoring vibration of the primary NH2 from 
the lysine and hydroxylysine amino acids showed a poor intensity in the 1555 
to 1575 cm-1 spectral band. Additional to this, the unstable formation of a Schiff 
base leads to the formation of a secondary amine, which not only justifies the 
previous finding, but it is a characteristic reaction of the crosslinking occurring 
in collagen, which is reflected by a decrease in the intensity of the 1555 to 1575 
cm-1 spectral band. 
 
In tissue engineering applications, collagen-based scaffolds are commonly used 
due to the properties that collagen provides to human tissues. An example of a 
collagen-based scaffold would be the three-dimensional collagen hydrogels that 
are widely used in the bioengineering field129-130 and that can be produced 
through a wide variety of experimental designs and/or under crosslinking 
methods to provide more durability to these in vitro models. Hwang and 
Lyubovitsky et al. have previously used characterisation methods such as 
second harmonic generation (SHG), fluorescence spectroscopy and 
transmission electron microscopy (TEM) to provide a basic understanding of 
the structural effects of collagen crosslinking, polymerisation temperature and 
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initial collagen concentration in 3D collagen hydrogels respectively.131 
However, additional information at the molecular level about the molecular 
effects that these factors can cause in hydrogel scaffolds is still very much 
needed. Hence to cover this gap, Hwang and Lubovitsky et al. used Raman 
spectroscopy to monitor structural changes in collagen hydrogels after exposure 
to the factors previously mentioned. The crosslinking reagents used were 
glyceraldehyde, 1-Ethyl-3-(3-dymethilaminopropyl) carbodiimide (EDC), and 
EDC/N-hydroxysuccinimide (NHS).  
 
Findings showed that out of all three reagents, glyceraldehyde caused the most 
distinctive modifying effect at the molecular level of collagen. For the control 
collagen hydrogels, peaks in the spectral region of 800 to 1000 cm-1 were 
reflected at 814, 846, 871, 921 and 936 cm-1.131 After collagen hydrogels were 
exposed to glyceraldehyde, the 814 cm-1 peak became sharpened and an increase 
in the intensity of the 936 cm-1 band located in the 936/921 doublet was clearly 
noticed. These spectral differences might be due to an increase in the packing 
organisation of the hydroxyproline/proline residues and the backbone of 
collagen protein. The 814 cm-1 bands remained in the same frequency as in 
collagen hydrogels, indicating no conformational change of the protein 
backbone after glycation. Additionally, bands at 846 and 871 cm-1 detected in 
the collagen hydrogel sample had an increase in frequency after samples were 
exposed to glyceraldehyde (855 and 877 cm-1). These spectral bands correlate 
with the findings of Frushour and Koenig where collagen from bovine Achilles 
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tendon was analysed and #  (C-C) of proline and hydroxyproline rings were 
reflected at 856 and 876 cm-1, respectively.132 
 
Furthermore, Amide III region also indicated spectral differences after 
crosslinking of collagen. The shift in frequencies of the Amide III bands, 
1241/1268 cm-1 reflects conformational changes in the secondary structure of 
collagen. After being exposed to crosslinking reagent glyceraldehyde, these 
peaks were shifted at 1247/1283 cm-1. Spectral differences in the Amide III band 
sheds light over the secondary structure of collagen protein. These shifts in 
frequencies might be a result of a drastic reorganisation of the orientation of the 
collagen fibres during crosslinking.131,133 
 
There was also an increase in intensity in the CH bending mode at 1450 cm-1 
and the appearance of 1468 cm-1 band in the glycated samples. Changes in 
intensities of the former peak might be an indication of changes in the amount 
or length of the CH groups of arginine and lysine residues and the latter peak 
might indicate modifications around these two amino acids.134 It is believed that 
these changes occur because the amino group –NH2 of lysine or arginine, which 
can easily react with the aldehyde group of the glyceraldehyde component. An 
increase in intensity was also seen in the 1604 cm-1 band after exposure to 
glyceraldehyde. Stretching vibrations from the C=C bond in the phenylalanine 
and tyrosine aromatic rings were reported at 1604 cm-1. These residues can 
easily react to form AGE’s. In fact, it was believed that an increase in the 
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formation of arginine-hydroxy-triosidine and lysine-hydroxy-triosidine135 
directly reflected in the intensity of 1604 cm-1, which suggested the formation 
of AGE’s adducts.136 
 
Collagen type I is a fibril-like molecule composed of triple helical structured 
fibrils arranged in a staggered array with characteristic gaps known as the D-
period.17 At least in bone, collagen type I represents 90% of its organic matrix, 
and the mineralisation process usually starts in the D-period gaps. These 
structural characteristics increase the tensile strength and toughness of the bone 
itself by promoting the crosslinking of collagen. Lysyl oxidase (LOX) is an 
enzyme that covalently binds to lysyl and hydroxylysyl residues of the collagen 
molecule producing and aldehyde compound.137 However, these enzymatic 
covalent crosslinks are less frequent in aging and in diabetes or osteoporosis.138 
It is believed that exercise induces favourable changes to collagen molecules 
reflecting in an increase in maintaining collagen in its normal morphology.139 
This by increasing the activity of lysyl oxidase as a balance to β-APN-driven 
changes in collagen. However, it is still unclear what conformational changes 
occur at the nanoscale level in the collagen molecule and how these changes 
may affect bone strength and fracture resistance. Hammond and Wallace used 
Raman spectroscopy to characterise, at the nanoscale level, the conformational 
changes of collagen type I from left tibiae tissue caused by exercise and β-APN 
treatment in a eight-week-old female mice.140 
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Collagen type I in bone tissue undergoes several post-translational 
modifications that lead to a specific type of crosslinking. This crosslinking plays 
an important role when it comes to the mineralisation process of bone tissue. 
When crosslinking of collagen is altered, so is its structure and thus its 
mechanical and structural properties reflect poorly on bone tissue.141,142 An 
alteration in the crosslinking pattern at the microscopic level can be enough to 
compromise the mechanical properties, even if there is no alteration in the 
inorganic matrix component.142 Hence, this is why crosslinking of collagen is 
considered to play a crucial role in the quantification of bone strength for both 
animals and humans.143-144 Post-translational modifications play a crucial role 
in the normal crosslinking of the collagenous matrix.  
 
Recent studies of crosslinked collagen and tissue models were characterised 
with FTIR to detect spectral bands for PYD and DPD.145 The ratio of these bands 
was calculated with a method described by Paschalis et al. Later on, this method 
was applied to Raman spectroscopy by Mandair et al. although it has not been 
properly recognised to date.146,147 Therefore in this study, S. Gamsjaeger et al. 
reproduced the same experimental procedure as Paschalis et al. but using Raman 
spectroscopy instead.148 It was found that bone tissue that didn’t contain an 
apparent trivalent crosslink content had no 1660 cm-1 band in their second 
derivative spectrum. Additionally, all samples showing a 1660 cm-1 band 
exhibited a linear correlation between the area of that peak and the content of 
PYD in the fractions analysed. Furthermore, it was also found that fractions of 
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peptides with enriched pyrrole (PRL) didn’t exhibit a 1660 cm-1 band in their 
second derivative spectrum. These findings support the idea that the 1660 cm-1 
is characteristic of the trivalent-collagen cross-linking of PYD. This method was 
also tested in whole tissues such as human bone, dentin, and predentin and 
porcine skin. It is important to mention that the dermis of skin contains a 
different type of crosslinks to bone. Even though both tissues are formed mainly 
of collagen type I, there is no hydroxylation of the lysine residues of the 
telopeptides in skin, hence there is a lack of PYD crosslinks.149,150  
 
 
1.10 SUMMARY 
Raman spectroscopy offers considerable potential for the analysis of 
conformational changes in collagen, which occur in progressive physiological 
processes, such as, wound healing and ageing as well as pathologies involving 
connective tissues and following the impact of diabetes on normal wound 
healing and ageing. This characterisation technique is a non-invasive technique 
allowing the sample to undergo many other types of characterisation methods. 
In addition, minimal sample preparation and in some cases no sample 
preparation is required. Raman spectroscopy has already established a spectral 
profile of particular bonds in collagen molecule. Therefore, it can easily identify 
biochemical differences occurring in collagen at different stages of a 
physiological and/or pathological process.  
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This literature review points out the main regions (lipids, amides and 
hydroxyproline and proline regions) that are frequently involved in the 
conformational changes of collagen. This has been achieved by probing into 
different stages of a process obtaining a spectral profile specific for each stage. 
By comparing all biochemical profiles, the biochemical differences among 
different stages can be established obtaining an insight into the biochemical 
pathway of a disease.  
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2 HYPOTHESIS 
Will Raman spectroscopy identify biochemical changes occurring in the process 
of contraction as a function of time? 
 
3 AIMS AND OBJECTIVES 
1. Produce TEBM models and analyse the degree of contraction with 
Raman Spectroscopy. 
2. Establish a spectral profile of a control model at different time intervals 
of contraction. 
3. Incorporate β-APN into the models and monitor the effect it has on the 
contraction of models. 
4. Establish a spectral profile of the drug-containing models at the time 
intervals of contraction. 
5. Consruct a chemometric modelling system to analyse spectral data. 
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4 MATERIALS AND METHODS 
4.1 PRODUCTION OF A TEBM MODEL  
 
The production of a TEBM model involves a long process of preparation 
beforehand. For an easier understanding this process can be described under the 
next main topics. 
 
4.1.1 ORAL BIOPSY 
Fresh human buccal mucosa tissue was obtained from an oral biopsy procedure 
after obtaining Research Ethics Committee’s (RECs) authorisation and patient’s 
approval. The oral biopsy was obtained and worked with under the license of 
Human Tissue Authority (HTA) 12179. It was cut into ~0.5 cm2 and it was kept 
for two hours in a solution containing (i) phosphate buffer saline (PBS), (ii) 
100$g/mL streptomycin and (iii) 1.2$g/mL of fungizone. Following this, the 
sample was then transferred to a universal tube containing 0.1% (w/v) Difco 
trypsin (DT) solution and left overnight in the fridge for fresh tissue samples at 
4ºC. After being incubated overnight in trypsin solution, oral keratinocytes 
(O.K.) and oral fibroblasts (O.F.) were ready to be isolated from the biopsy.   
 
4.1.2 ISOLATION OF ORAL KERATINOCYTES 
Oral keratinocytes were isolated following Goberdhan et al. protocol,151 which 
is a modification from Rheinwald and Green’s method.152 This process is 
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explained in detail in references stated above. Briefly, after identifying the 
epithelium from the dermis, the oral biopsy was gently placed in a Petri dish 
with a 5mL of Green’s medium (composition of this medium can be found in 
Appendix section 9.1) to keep the sample hydrated. With the epithelium facing 
up, a corner of the dermis was pinched and slightly pressed against the Petri dish 
with a scalpel; this was used as an anchor site when trying to remove the 
epithelium. The oral epithelium was gently peeled off from the lamina propia 
with a pair of forceps. Oral keratinocytes were obtained by softly scraping with 
a scalpel blade the top region of the papillary surface and the bottom layer of 
the oral epithelium. Each sample was scratched for 5 minutes to make sure most 
keratinocytes were in the medium. Once this was done, the epithelial layer was 
discarded and the lamina propia was set aside for future oral fibroblasts 
isolation. Subsequent to this and in order to promote cell expansion, cell 
suspension was then placed in a universal tube and centrifuge at 1000rpm during 
5min. Since the supernatant was still cloudy, it was transferred to a new 
universal tube and centrifuged again at 1000rpm/5min (this with the main 
purpose of keeping every possible cell from the biopsy). The pellet left in the 
first universal tube was then suspended with 10mL of Green’s medium and then 
transferred to a T75 flask, which surface was previously covered by a feeder 
layer of i3T3 fibroblast. The pellet obtained from the second universal tube was 
then suspended in 2mL of Green’s medium and finally incorporated into the 
T75 flask. Primary cells were nourished and cultured in Green’s medium -which 
was changed every two to three days- until reaching around 80% confluence. 
After seven days, primary oral keratinocytes had covered most of the available 
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surface area and were ready to be subcultured. The latter was carried on by 
washing the substrate with 0.02% EDTA for 5 min in the incubator, followed 
by a quick rinse with 10mL of PBS and finally replacing these two with an 
aliquot of 0.1% trypsin to detach cells from the plastic. Cells were stored in 
trypsin for 5 minutes in an incubator at 37°C followed by the standard protocol 
for passaging cells. Cells were split in 1:3 ratio for passage 1 and 1:4 ratio for 
passage 2. Protocol for passage of cells has been added to Appendix section, 
9.4. After cell expansion, cells were stored in liquid nitrogen, Appendix section 
9.5. 
 
4.1.3 ISOLATION OF ORAL FIBROBLASTS 
To isolate oral fibroblast from the biopsy, the dermis set aside after removing 
the epithelium was then rinsed with PBS. Further to this, dermis was then placed 
in a Petri dish with 5mL of fibroblast medium and grinded continuously with 
the scalpel blade until it was properly minced. It was then transferred to a T25 
flask with 10mL of 0.5% collagenase A. Minced dermis was then kept overnight 
in an incubator at 37°C to allow collagenase to cleave all collagen fibres. Next 
day, suspension was transferred to a universal tube and centrifuged at 
2000rpm/10min. The remaining pellet was suspended in 5mL of fibroblast 
medium and then transferred to a T25 flask. The supernatant was placed in a 
second universal tube and centrifuged again at 2000rpm/10min. The remaining 
pellet was then suspended with 5mL of fibroblast medium. Cell suspension was 
then added into the T25 flask and stored in the incubator at 37ºC/5CO2. Primary 
fibroblasts were cultured in fibroblast medium and passaged to a T75 flask after 
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reaching 80% confluence. Cells were split at 1:2 ratio for all passages done. 
After cell expansion, cells were stored in liquid nitrogen. 
 
To produce an in vitro oral mucosa model, oral keratinocytes and oral fibroblast 
were used at passage 3 and passage 5, respectively. 
 
4.1.4 PREPARATION OF DE-EPIDERMISED DERMIS 
To prepare the de-epidermised dermis (DED), human cadaveric skin (Euroskin) 
previously sterilised and preserved in glycerol was placed into a plastic flask 
container with 1M of NaCl and kept for over 24 hours in the incubator at 37ºC. 
To completely remove any remaining glycerol, skin was then stored in PBS for 
over 72 hours, replacing the PBS every 24 hours. After washing off the glycerol, 
the epithelium was then easily removed from the dermis and the latter was then 
cut in small squares of 2cm2 size. To produce the in vitro oral mucosa model, a 
total of six samples (six DED squares) were prepared and placed in a six-well 
plate. The rest were transferred to a container with Green’s medium and stored 
in the incubator. A protocol of this process can be followed in the Appendix 
section 9.3. 
 
4.1.5 PREPARATION OF TEBM MODEL 
Six DED samples were placed in a six-well plate with the papillary surface 
facing upwards. Six sterile metal rings were allocated on top and on the centre 
of each DED sample and slightly pressed down to make a seal between the DED 
and the stainless-steel ring. For each well plate, the surface area outside the 
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metal ring was then covered with Green’s medium and subsequent to this, 3x105   
oral keratinocytes and 1.5x105 oral fibroblasts (composition of this medium can 
be found in Appendix section 9.2) were seeded simultaneously inside the metal 
ring. The remaining space within the metal ring was then filled up with Green’s 
medium until reaching a cell suspension of ~500$L. All six samples were left 
in the medium and placed in the incubator at 37°C for the first 24 hours. At the 
next day, medium within the ring was carefully replaced with fresh medium and 
the experiment was placed back into the incubator. Twenty-four hours later, 
metal rings were carefully removed, and the seeded area was carefully excised 
with a scalpel. Samples were then kept in the incubator for 24 hours more. The 
next day, each sample was then placed onto metal grids raising them to an air-
liquid-interface (ALI). This was considered day 0 of the experimental design. 
 
The ALI stage was reached by replacing the medium with fresh Green’s medium 
making sure that the undersurface of the DED was in contact with the medium 
and the top surface was directly exposed to the air. These three stages can be 
seen in Figure 9. All six samples were placed back in the incubator and cultured 
for 28 days and medium was replaced every two to three days. 
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Figure 9. Schematic representation of the three main steps towards preparing a 
TEBM model. A) Seeding of both O.K. and O.F. within the metal ring. B) 
Dermal matrix is kept submerged for ~48 to 72 hours. C) Dermal matrix is raised 
to an ALI. 
 
4.1.6 PREPARATION OF A TEBM MODEL WITH b-APN 
To produce the in vitro oral mucosa samples with b-APN, the same procedure 
described in section 4.5 was followed. However, once samples were raised to 
an ALI, a solution of Green’s medium containing 200µg/mL of b-APN was used 
during the rest of the experiment every time medium needed to be replaced 
(instead of using only Green’s media). 
 
4.1.6.1 PREPARATION OF b-APN STOCK SOLUTION 
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To inhibit contraction in the in vitro oral mucosa samples, a solution of medium 
with 200µg/mL of b-APN was added, but to do this, a 10mL of 20mg/mL stock 
solution was prepared following the steps described below: 
1. 0.2g (200mg) of b-APN was weight into a universal tube. 
2. 10 mL of Green’s medium was added. 
3. The solution was shaken until dissolved and then filter sterilised. 
4. It was then stored at 4°C 
To make a solution of medium with 200µg/mL b-APN, a 1:100 dilution of the 
20mM b-APN stock solution in medium was performed. For example, 300µl of 
b-APN stock were added when using a 30000µl of media. 
 
4.2 EXPERIMENTAL DESIGN 
In order to characterise contraction as a function of time, six TEBM samples 
were made, each of them representing a time point previously established, as 
can be seen in Figure 10.  
 
At day 0 –when samples were raised to an ALI– all six models were individually 
photographed in order to keep a record of their original diameter. Additional to 
this, sample 1 (representing day 0) was then fixed in 3.7% formaldehyde for 24 
hours to be further prepared for both histological and Raman analysis. All this 
was done to characterise and keep track of the initial state of contraction at day 
0 of ALI. The whole process was repeated at each different time point and all 
remaining samples were photographed every time a time point was reached. For 
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instance at day 3, five pictures were taken, respectively to the remaining time 
points. Sample 1 was no longer in the six-well plate since day 0 was already 
being characterised. This experiment was done in triplicate leading to 18 
samples in total.  
 
 
Figure 10. Six TEBM samples in a six-well plate. Each 3D sample is 
representing a time-interval. Sample 1 representing day 0; Sample 2 
representing day 3; Sample 3 representing day 7, and so on until sample 6 
representing day 28. All experiments were done in triplicates 
 
 
 
 
 MATERIALS AND METHODS 
Characterisation of Contraction 
 in a TEBM Model 
 
 76 
5 CHARACTERISATION OF CONTRACTION IN A 
TEBM MODEL 
 
5.1 DIMENSIONAL ANALYSIS  
To measure contraction as a function of time, each individual sample was 
photographed with a camera placed vertically above the six-well plate. A ruler 
was placed right next to the sample in order to set a scale bar and be able to use 
it as a reference when calibrating the image Figure 13. Images were opened in 
ImageJ software to calculate the surface area. The perimeter of the sample was 
carefully traced on the screen and by using the “analyse feature” the area of the 
delimited sample was calculated based on the scale bar previously established. 
The area calculated at day 0 was established as the starting point of contraction 
and therefore it was set as 100% of the remaining surface area. The area 
calculated for the remaining time points was reported based on this initial 
measurement. Once the areas of all time points were calculated, data was 
transferred to Excel software and plotted as remaining surface area as a function 
of time.  
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Figure 11. Experimental design explaining how samples were representing a 
specific time point, and how they were photographed every time a time point 
was reached. Samples were then fixed to be further analysed once they had 
reached the time points they were representing. This is why the sample 
variation. 
 
 
 
Day 0 Day 3 Day 7 Day 14
SAMPLE 3.
(photographed at day 
0,3, and day 7)
SAMPLE 2.
(photographed at day 
0 and day 3)
SAMPLE 1.
(photographed at 
day 0)
SAMPLE 4.
(photographed at day 
0,3,7, and day 14) 
SAMPLE 1 was then fixed and 
processed to characterise contraction 
at day 0
SAMPLE 2 was then fixed and 
processed to characterise contraction 
at day 3
SAMPLE 3 was then fixed and 
processed to characterise contraction 
at day 7
SAMPLE 4 was then fixed and 
processed to characterise contraction 
at day 14
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Figure 12. Measurement of the surface area was done with Image J. All samples 
were photographed at each timepoint. At the starting point of contraction (day 
Day 0 Day 3 Day 7 Day 14
Surface area was calculated for day 0 
on all 4 samples and its triplicates 
(n=12 measurements in total)
Surface area was calculated for day 3 
on all remaining 3 samples and its 
triplicates (n=9 measurements in 
total)
Surface area was calculated for day 7 
on all remaining 2 samples and its 
triplicates (n=6 measurements in 
total)
Surface area was calculated for day 
14 on the remaining sample and its 
triplicates (n=3 measurements in 
total)
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0) all samples were available and hence n=12 photographs were obtained to 
measure surface area for day 0. At day 3, n=9 samples were photographed (since 
samples representing day 0 were already been fixed and processed for further 
analysis). At day 7, n=6 and at day 14 n=3. All these was done in triplicates. 
The absolute average and SD for each time point has been display in Table 11 
and Table 12. 
 
 
Figure 13. Measuring contraction as a function of time. In the image on the left, 
a ruler was used as a reference unit of measurement to set a scale and calibrate 
the image. In the image on the right, the perimeter of the sample was traced 
using ImageJ software to calculate the surface area at different time points. 
 
5.2 TISSUE PROCESSING 
After being fixed in formaldehyde, all six TEBM samples were placed carefully 
in grey tissue cassettes and labelled accordingly. To replace the water content 
Setting a scale bar to calibrate 
the image
Tracing the margins to calculate sample 
area
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within the tissue, samples were wax embedded with a tissue processor Leica 
TP1020. Therefore, samples were submitted to different alcohol concentrations. 
After samples were dehydrated, they were then transferred to xylene solution to 
displace the amount of alcohol within the tissue. To finalize the process, samples 
are then embedded in paraffin containers to replace the xylene content with wax, 
Table 7. Samples were then removed from the cassettes and they were 
individually set up in a vertical plane inside metal boxes to get wax embedded. 
Samples were then cooled on iced surface in a Leica EG1160 (embedding 
centre) equipment to finally form wax blocks. It is important to mention that 
samples representing day 21 and day 28 contracted so much that after 
dehydrating and wax embedding them, they became quite brittle and very 
difficult to handle. After careful consideration it was then decided that day 21 
and day 28 were not crucial for the culturing system of the engineered grafts 
and so it was decided to continue with only four remaining time points instead 
of six.  
 
Table 7. Steps and schedule for tissue processor Leica TP1020. 
Step Time 
70% IMS (x2) 1 hour each 
80% IMS 1.5 hour 
85% IMS 1.5 hour 
90% IMS 1.5 hour 
95% IMS 1.5 hour 
100% IMS (x2) 1.5 hour each 
Xylene (x2) 1.5 hour each 
Paraffin wax (x2) 2 hour each 
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Following wax embedding, and using a microtome Leica RM2145, tissue 
sections were cut in 6µm and 20µm thickness to be used in Haematoxylin and 
Eosin (H&E), and RS, respectively. For H&E staining, the 6µm samples were 
dewaxed following the protocol described in Table 9. For Raman 
characterisation, dewaxing of the 20µm samples was done following the 
protocol described in Table 8. This protocol is different than the one used for 
H&E staining because samples utilized for Raman analysis were thicker (20 
µm), which required longer time in xylene and alcohol solutions to remove as 
much as possible the amount of wax. 
 
 
Table 8. Dewaxing protocol for Raman spectroscopy based on Mian et al. 
2014 
 
 
 
 
Dewaxing Protocol 
Xylene 30 min 
100% Ethanol 5 min 
70% Ethanol 5 min 
50% Ethanol 5 min 
Distilled Water 1 min 
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Table 9. Dewaxing protocol for H&E staining 
 
 
 
 
 
 
 
 
 
 
 
5.3 HAEMATOXYLIN AND EOSIN STAINING  
All samples were stained with both H&E following the protocol described in 
Error! Reference source not found.. Immediately after, stained tissue sections 
were mounted and sealed off with cover slips and left to dry for further analysis 
with Raman Spectroscopy  
 
5.4 RAMAN SPECTROSCOPY  
To analyse samples with RS, wax was removed from the sample slide by using 
the protocol established in Mian et al. 153. The protocol is described in detail in 
Table 8. After all four TEBM samples were dried, they were analysed with RS 
Dewaxing Protocol 
Xylene 3 min  
100% IMS 1 min 
70% IMS 30 sec 
Distilled Water 1 min 
Haemotoxylin 
Tap Water 
Eosin 
Tap Water 
Tap Water 
70% IMS 
100% IMS 
Xylene 
1.5 min 
4 min 
5 min 
dunk 
dunk 
dunk 
30 sec 
dunk 
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Thermo DXR Raman Microscope using a laser wavelength of 532 nm diode 
laser and employing a 50x LWD objective. All samples were analysed under 
the same parameters previously established. This can be found in Table 10. For 
each sample, twenty random points per layer were analysed making a total of 
60 spectra per sample Figure 14. These spectra were further compared to H&E 
stained section images. 
 
Table 10. Raman spectroscopy parameter 
Raman Spectroscopy Parameters 
Exposure Time 10 sec 
Sample Exposure 20 sec 
Corrections Fluorescence 
Laser Power 10 mW 
Aperture 25 $m pinhole 
Objective 50x lwd 
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Figure 14. Raman characterisation of TEBM model. Twenty random points 
collected per layer per sample (time point). 
 
5.4.1 SPECTRAL PROFILES OF CONTRACTION  
Establishing Spectral Profiles of Contraction as a Function of Time. 
Fluorescence correction (polynomial 6), wax subtraction and baseline 
correction were performed on all spectra using OMNIC™ Software (Thermo 
Scientific Nicolet, U.S.A.). For each time point of contraction, with and without 
b-APN, a spectral profile of each layer (epithelium, papillary and reticular) was 
obtained by calculating the average of 60 spectra collected from a specific layer 
within a specific timepoint (this number includes triplicates). This was 
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performed by using OMNIC and Prism7 Softwares (GraphPad Software, 
U.S.A.).  
 
5.4.2 MULTIVARIATE ANALYSIS METHODS  
Principal Component Analysis (PCA). To understand what is occurring with 
the in vitro oral mucosa grafts as a function of time, it is important to interpret 
as accurately as possible the information contained in the large amount of 
spectral data collected. However, an extensive amount of information hidden 
within that spectral data is to be expected and detecting differences within large 
amount of spectra can be too complex and sometimes impossible for the eye to 
identify. PCA is an unsupervised multivariate analysis method that will identify 
how, where, or at which point samples differ from one another. It also highlights 
the variables that are mostly responsible for these differences, and whether or 
not those variables have a co-dependent relationship between them. In this 
research project, all the spectral data was processed and analysed using The 
Unscramble X 10.2™ Software (Camo Software, Oslo, Norway). Using PCA 
method, data was analysed considering variables such as type of samples, time 
points, spectral regions and layer of the oral mucosa, as it can be seen in Figure 
17. Previous to the PCA analysis all data was processed using the same 
conditions: Standard Normal Variate (SNV), offset baseline correction and 
Savitzky-Golay smoothing.  
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Organisation of Spectral Data. To analyse all spectral data in an organised 
manner, a combination of variables were considered to cover three main fronts. 
To find how the data was different from one another, the type of sample was the 
variable of choice (e.g. grafts contracting naturally and/or grafts contracting 
under the influence of b-APN). To find at which point samples differed from 
one another, different time points were the variable in charge (i.e. contraction at 
day 0, day 3, day 7, day 14, etc.). Furthermore, to identify where did the spectral 
data differ between them, spectral regions were the variables of choice (e.g. 
lipids, amides, hydroxyproline and proline, fingerprint region, etc.). Taking into 
consideration these three variables, the multivariate analysis of the spectral data 
was organised and can be visualized in Figure 15 and Figure 16. This template 
was applied in each of the three layers of the oral mucosa model for both 
experiments. 
 
Cluster Analysis (CA). To corroborate the similarities and differences found 
by PCA, spectral data was also submitted to a Cluster analysis method. Cluster 
analysis is an unsupervised multivariate analysis method that aims to group 
samples into specific number of clusters based on their similarities. This method 
organises data into different groups, which reflect useful or relevant 
information. In this instance for example, contraction as a pathological process 
occurring in the oral mucosa model could have some spectral variations over a 
specific amount of time. Cluster analysis was applied on this spectral data to 
detect how these spectral variations organised it selves in different clusters. The 
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Wards method was the method of choice for the cluster analysis. This analysis 
calculates the existing difference between one specific sample and the cluster 
centroid and also between two samples. In this way, a set of samples randomly 
allocated in different clusters will reallocate into the cluster that has the shortest 
distance between the sample’s value and the cluster centroid. 
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Figure 15. System template used to organise and analyse spectral data per layer. 
E: indicates regions that were discussed in the epithelium layer. P: is marking 
regions discussed in papillary layer. R: indicating regions discussed in reticular 
layer. This system was applied on every layer for both TEBM and TEBM with 
b-APN). 
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Figure 16. Comparison template of control TEBM vs TEBM/b-APN model. 
This system corresponds to the analysis of spectral data. E: indicating regions 
analysed by the epithelium layer. P: regions discussed in the Papillary layer. R: 
regions discussed in the Reticular layer.  
 MATERIALS AND METHODS 
Characterisation of Contraction 
 in a TEBM Model 
 
 90 
 
 
Figure 17. Experimental design for Raman data with the main variables 
considered for the analysis of the spectral data. 
 
 
TEBM	models 
	Layers 
TEBM  
(control)
TEBM  
with β-APN
Day 0 
Epithelium
Papillary
Reticular
Day 3
Epithelium
Papillary
Reticular
Day 7
Epithelium
Papillary
Reticular
Day 14
Epithelium
Papillary
Reticular
	Time	points x3 
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6 RESULTS AND DISCUSSION 
 
Due to their versatility, tissue-engineered buccal mucosa grafts have been used 
not only for intraoral applications, to repair cleft palates or for reconstructive 
surgery in head and neck cancer, but also in extraoral applications to replace 
scarred tissue in the urethra. A central issue in these applications is that, when 
applied clinically in the patient, tissue-engineered buccal mucosa grafts exhibit 
contraction that contracts further after implantation to the injury site which can 
lead to incorrect functionality of the tissue. Although extensive research has 
been dedicated to the study of contraction in oral mucosa grafts, there is an 
urgent need for a better understanding of the nature of contraction.120119 
Currently, there is no method available to accurately measure the crosslinking 
of collagen at the biochemical level, as conventional assays 
(Electrochemiluminescence ECLIA to indirectly measured collagen synthesis 
through the concentration of amino terminal propeptide of type I (P1NP), and 
Sircol soluble collagen assay) are tedious and not very reliable. Raman 
spectroscopy is capable of identifying biochemical changes occurring in 
collagen type I, III and IV. Therefore, this gives us the opportunity to analyse 
and characterise the progressive process and extent of physical contraction 
occurring in oral mucosa grafts using Raman spectroscopy technique. This 
chapter reports on the results obtained from characterising the progressive 
process of contraction with Raman spectroscopy, over a period of 14 days. 
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6.1 DIMENSIONAL ANALYSIS 
The extent of contraction occuring in a TEBM model was analysed at different 
time points. Contraction at day 0, 3, 7, 14, 21 and 28 were the previously 
established time intervals. Following the same protocol of preparation, six 
TEBM models were produced, one for each time point. The degree of 
contraction progresses as a function of time. Whenever a time point was 
reached, all samples were photographed Figure 18. Subsequently, the sample 
assigned to that time interval was fixed in order to be analysed and characterised 
to record the extent of contraction achieved up until that time point. 
 
 
Figure 18. Digital image of sample #4 showing the extent of contraction from 
the starting point at day 0 up until day 14 of in vitro culture. This is a 
representation of sample 4 at different time points. Each image is showing 
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contraction at a different day. Sample #4 was assigned as day 14, once it reached 
day 14, it was then fixed and processed for further analysis. 
 
The graph in Figure 19 represents the extent of contraction seen per time point. 
An average of the remaining surface area and their respective standard deviation 
values (SD) have been calculated and included in Table 11. All triplicates 
followed a similar tendency when contracting and according to the dimensional 
analysis, the highest activity of contraction occured between day 0 and day 3. 
As it can be seen in Table 11, the remaining surface area at day 3 is around 52% 
in average. Then from Day 3 to Day 7 samples contracted slightly more, 
showing a remaining area of 37% in average. As time point increases, so does 
the extent of contraction and hence the remaining surface area is slightly 
reduced. From day 7 to day 14 the graph reaches a pleateau indicating not much 
of a difference between the remaining area of day 7 and day 14. 
 
Table 11. Percentage of contraction in a TEBM model (and its triplicates). The 
average remaining surface area was calculated by including all the available 
measurements per time point. 
 
 
% of Remaining Surface Area in TEBM Models (triplicates)
Time points 
(days) Average (cm
2) SD %
0 0.813 (n=12) 0.10 100 
3 0.423 (n=9) 0.05 52
7 0.300 (n=6) 0.06 37
14 0.286 (n=3) 0.03 35
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Figure 19. Percentage of remaining surface area as a function of time. the solid 
navy-blue line represents the average and SD calculated for each time point. 
(one-way t test was performed, p<0.0214, *) 
 
 
Figure 20. Unpaired t-test statistical analysis of surface area of control model 
as a function of time. day 0 vs day 3 (p<0.0001, ****). Day 3 vs day 7 
(p<0.0007, ***). Day 7 vs day 14 (p<0.7106, ns). 
0 7 143 11
0.0
0.2
0.4
0.6
0.8
1.0
Time points (days)
Re
m
ain
ing
 
Su
rfa
ce
 A
re
a (
cm
2 ) 
Contraction in 
TEBM Model
*
Day 0 Day 3 Day 7 Day 14
0.0
0.2
0.4
0.6
0.8
1.0
Re
m
ain
ing
 
Su
rfa
ce
 A
re
a (
cm
2 ) 
****
ns
***
					
RESULTS & DISCUSSION.  
Characterising Contraction in a  
TEBM Model with Raman Spectroscopy  
 
 95 
6.2 HISTOLOGICAL ANALYSIS 
When tissue sections are stained with H&E, the hemalum is chemically binded 
to the DNA within the nuclei, giving the appearance of blue dots when seen in 
the histological images. In this case, the blue dots on any of the images shown 
below, strongly suggests the presence of nucleus where the stain can bind to. As 
can be seen in Figure 21 all TEBM samples exhibited the formation of a 
stratified epithelium characteristic of the oral mucosa. A progressive increment 
in the stratified layers of the epithelium can be appreciated as a function of time. 
Therefore, there is a notorious difference between day 0 and day 7, where the 
epithelium layer seemed to be thicker when compared to the starting point of 
contraction. Similar case with day 14. As time points get longer, the thickness 
of the epithelium increases. Images in this figure show the similarity between 
these engineered models and native oral mucosa structure. 
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Figure 21. Histological images (taken with 20x objective) of all four TEBM 
models. In all four images it can be seen how the epithelium increases in 
thickness as a function of time. 
 
6.3 RAMAN SPECTROSCOPY CHARACTERISATION 
All four samples and their respective triplicates were analysed with Raman 
Spectroscopy. The epithelium, papillary and reticular layer were the three main 
layers from the TEBM models to be characterised. Twenty spectra per layer 
were collected. Considering that each sample was made in triplicates, there were 
60 spectra per layer/time point. An average of those 60 spectra was calculated, 
					
RESULTS & DISCUSSION.  
Characterising Contraction in a  
TEBM Model with Raman Spectroscopy  
 
 97 
making a spectral profile for each layer at each specific time point. The purpose 
of this was to establish and compare the spectral profiles and detecting the 
differences occurring between each day of contraction. 
 
6.3.1 EPITHELIUM LAYER 
Briefly, the oral epithelium is the outermost layer directly exposed to the oral 
environment and is mainly formed by squamous cells that are uniformly 
distributed along the basement membrane. As cells start differentiating into 
keratinocytes, they start migrating to the uppermost layers forming what is 
known as the stratified epithelium. In this study, contraction in the TEBM 
models was characterised and analysed. The epithelium of four different 
samples was analysed and their spectra were averaged to calculate a spectral 
signature. A spectral profile for each specific time point has been illustrated in 
Figure 22. The highest activity of contraction was seen between day 0 and day 
3. 
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Figure 22. Raman characterisation of contraction in the epithelium layer at 
different time points. Each time point is represented by their spectral profile. 
Each profile is an average of 60 spectra. In this figure, the most notorious 
differences between time points have been highlighted and expanded. These 
regions have been labelled as followed, a) Amide I, b) Amide III, and c) 
Aminoacids & Nucleic Acids region. 
 
Together with this, the qualitative Raman analysis of contraction at the 
epithelium level indicates that most notorious changes were reflected at day 3. 
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Figure 22 highlights spectral differences that are easy to identify by the naked 
eye, being Amide I, Amide III and Amino acids regions the most notorious. To 
validate these observations, Raman statistical analysis –via MVA techniques– 
was performed on all spectral data to spot the most relevant biomarkers in an 
accurate manner. The main spectral differences highlighted by the PCA method 
were Lipids, Amide I, Amide III and Amino acids region, which are described 
below. 
 
Lipids. At the initial state of contraction, 
at day 0, there is a lower activity on the 
stretching vibration of the CH bond than in 
day 3. This stretching vibration is reflected 
at 2918 cm-1, coming from the CH located 
mainly in lipids 27. According to the PCA 
of lipids region in Figure 23, by day 3 into 
contraction this activity has notoriously increased causing a separation between 
both time points. The stretching vibration of CH bond is now higher in day 3. It 
is also noted that there is a higher activity from the asymmetric stretching (vas) 
vibration from both the CH3 and CH2 bonds, which is reflected at 2882 cm-1. 
Since lipids are a main component of cell membranes, this increase in activity 
of all CH bonds could be justified as an increase in the rate of triglycerides (TG) 
content. According to Ponec et al., the rate of TG content is somehow related to 
the stage of differentiation of keratinocytes cells.154 They have previously 
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reported that the TG content increases in air-exposed stratified keratinocyte 
cultures.154 It could be possible that by day 3 there has been an increase in the 
number of keratinocytes, due to the proliferation and mainly differentiation of 
squamous cells during the re-epithelialisation process, resulting in the 
stratification of the epithelium layer. 
 
At the final stage of contraction, from day 7 to day 14, notorious changes were 
detected. By day 7, the intensity of peaks at 2881 and 2846 cm-1 was higher than 
the average value. Which translates into a higher amount of activity from the 
vas(CH3,CH2) and the vs(CH3), respectively.27 However, according to the PCA 
in Figure 24, it seems that the intensity of these two bands significantly reduced 
by day 14. Since the re-epithelialization process is mostly done by day 14, 
differentiation and migration of keratinocytes is notoriously reduced. Hence, 
proliferation and adhesion between keratinocyte membranes is considerably 
lower than the activity presented at day 7. 
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Figure 23. PCA of lipids region (3100-2600 cm-1) at the initial stage of 
contraction. Spectral data from day 0 and day 3 are separated mostly by peaks 
at 2881 (PC-1 in brown) and 2918 cm-1 (PC-2 in green). Band at 2881 (PC-1) is 
responsible for 72% of the separation, while the 2918 cm-1 PC-2 accounts for 
9%. 
 
 
Figure 24. PCA of lipids region (3100-2600 cm-1) at the final stage of 
contraction. Spectral data from day 7 and day 14 were compared and analysed. 
Bands at 2881 and 2846 cm-1 account for 78% of the variation. Peak at 2881 
cm-1 was considered and individual component responsible for 4% of the 
separation. 
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secondary structure of the protein, going from an unordered structure to an α-
helix structure.27,70 In agreement with this, the PCA for Amide I region shows 
that most samples at day 0 have a stronger tendency towards an unordered 
structure, separating themselves from samples at day 3. Responsible for this 
separation is peak at 1676 cm-1, characteristic to unorganised secondary 
structures,131 and represented by PC-2. Whereas at day 3, an average of all 
samples is reflecting Amide I bond at 1658 cm-1. Accordingly, the score plot 
from Figure 25A is showing that most of the samples from day 3 have a lower 
activity than the average with respects to peak 1676 cm-1. It might be indicating 
a change in the secondary structure of a protein into the formation of an α-helix 
structure. This observation did not correlate with Dehring et al.25, who 
considered the aging process as a chemical factor that caused the crosslinking 
of collagen fibres resulting in an increase in a disordered secondary structure in 
the protein molecule. On the other hand, Guilbert et al. supported the statement  
that no conformational changes occurred in the triple-helical structure of 
collagen I during glycation process.155  
 
However, with the increase of crosslinking, it is reasonable to expect continuous 
formation of α-helix structure from the polypeptidic chains, increasing the 
rigidity of the oral mucosa graft. Together with this, two detectable peaks that 
were not present at day 0 emerged at 1616 and 1584 cm-1 at day 3 onwards into 
contraction. These peaks are representative of the stretching vibration of C-C 
from tyrosine and the bending mode of the C-C bond from phenylalanine, 
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respectively.131,27 It is well-documented that excessive activity from LOX 
enzyme promotes the excessive crosslinking of collagen fibres.156 However, 
LOX is incapable of inducing reactions without the presence of a cofactor 
known as lysyl-tyrosyl-quinone (LTQ), which derives from the di-oxo-
phenylalanine (DOPA) complex.157 This could be indicating that after the 
starting point of contraction, crosslinking of polypeptide chains resulted from 
the activation of LOX enzyme through cofactor LTQ, which oxidised the e-
amino group of lysine residues into highly reactive aldehydes. Justifying the 
presence of both tyrosine (1616 cm-1) and phenylalanine (1584 cm-1) at day 3 of 
contraction Figure 25D. Additionally, it would explain why most of the samples 
at day 3 have a higher activity of both peaks than samples at day 0.  
 
Furthermore, by day 7 amide I band kept reflecting a downshift in frequency. It 
went from 1658 at day 3 to 1655 cm-1. However, little to no difference was seen 
regarding the presence of both tyrosine and phenylalanine at this stage of 
contraction Figure 26. This correlates with the little difference in contraction 
seen between both time points.  
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Figure 25. A) PCA score plot of the amide I region: According to the PCA 
analysis, spectral data from day 0 and day 3 are mostly separated by PC-2 and 
PC-4 loadings. B) PC-2 accounts for 38% of the variation, represented by a 
positive value of 1676 cm-1 band. Bands at 1658, 1615 and 1605 cm-1 are 
considered the fourth component with a variation of 4%, showing a direct 
correlation between them. C) Spectral profile for day 0 in blue and day 3 in red, 
with all three peaks indicated by dotted line. D) T-test analysis of the direct 
correlation between 1652, 1615 and 1605 cm-1 bands at day 0 and day 3. Mean 
and SD values were reported as [mean, SD]. For peak at 1652, values were 
[1.2734, 0.0995] for day 0 and [1.3495, 0.1411] for day 3. For peak at 1615, 
values were [0.5987, 0.1014] for day 0 and [0.7573, 0.1057] for day 3. For peak 
at 1605, values were [0.5976, 0.1118] for day 0 and [0.7687, 0.1065] for day 3. 
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Figure 26. PCA score plot of the amide I region: According to the PCA analysis, 
spectral data from day 3 and day 7 are mostly separated by PC-2 and PC-3. PCA 
loadings of the amide I region: PC-2 accounting for 33% of the variation, 
represented by negative values of 1665 and 1657 cm-1 bands. PC-3, represented 
by a negative value of 1651 cm-1 and accounting for 8% of the variation. 
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deformed into blunt irregular bands. 
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to the PCA, the peaks responsible for separation between day 0 and day 3 are 
1336 and 1245 cm-1, representing 35% of the variation (PC-2). Based on the 
corresponding loadings, these two bands are indirectly correlated, hence if one 
increases the other one decreases Figure 27B (see loading PC-2). This 
correlates with Figure 27D, where the intensity at day 0 is significantly higher 
for 1243 cm-1 band (p<0.0001) and significantly lower for the 1335 cm-1 band 
(p<0.0001), when compared to day 3. Therefore, as reported by the PCA 
statistical analysis, there is a higher activity of the stretching vibration of C-N 
from the amide bond, 1245 cm-1, than in day 3. Interestingly, by day 3 this 
stretching vibration has reduced its activity and instead the twisting vibration of 
CH3 and CH2 has now increased, 1336 cm-1. Previous literature has reported that 
LOX transforms lysine residues into aldehydes via oxidation of the e-NH 
group.158 It could be possible that at day 0 there was no notorious activity from 
the CH3 and CH2 twisting vibration since LOX was in the process of inducing 
the aldehyde formation. Once the transformation had occurred, reactive 
aldehydes formed at the end of the side chains can easily react with other 
reactive terminal groups. Hence explaining an increase of the twisting vibration 
of CH3 and CH2 (mostly located in the side chains) as a result of the re-
accommodation of polypeptidic fibres. Intensity in all peaks mentioned above 
kept slightly increasing as a function of time. 
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Figure 27. A) PCA score plot of the amide III region: According to the PCA analysis, 
spectral data from day 0 and day 3 are mostly separated by peaks at 1336 and 1245 cm-1. B) 
PCA loadings of the amide III region: PC-1 accounting for 59% of the variation, represented 
by positive values of 1270 and 1240 cm-1 bands. PC-2, represented by a positive and negative 
value of 1244.89 and 1336 cm-1, respectively. These two peaks are considered the second 
component with the next highest variation of 35%, showing an indirect correlation. C) The 
amide III region is highlighted in grey, spectral profile for day 0 in blue and day 3 in red, 
with both peaks indicated by dotted line, a)1336, b)1245. D) T-test analysis of the indirect 
correlation between 1245 and 1336 cm-1 bands at day 0 and day 3. Mean and SD values were 
reported as [mean, SD]. For peak at 1245, values were [1.3980, 0.2134] for day 0 and [.9483, 
0.1563] for day 3 here. For peak at 1336, values were [0.8308, 0.1687] for day 0 and [1.1848, 
0.1534] for day 
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Figure 28. CA of Amide III region on Day 0 and Day 3 of contraction in a 
TEBM model. The unsupervised method clustered Day 0 and separate it from 
Day 3, complementing the results of the PCA. 
Day 0
Day 3
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Amino and Nucleic Acids. At day 0 on the 
initial state of contraction, well-defined 
peaks were reflected at 815, 854, 876, 898, 
920 and 937 cm-1. By day 3, biochemical 
changes due to contraction produced several 
spectral differences. Based on the statistical 
analysis, the PCA of amino acid and nucleic 
acids region (spectral range 980-600 cm-1) is shown in Figure 29. Similarities 
and differences between samples is shown based on the existing variation, 
representing 77% between both PC-1 and PC-3 accounting for 73% and 4%, 
respectively. A clear separation between time points can be seen when applying 
these two components. According to PC-1, Day 0 is characterised by a higher 
activity of stretching vibration of C-C from proline and lipids residues, 920 and 
873 cm-1, respectively 27. However, distinctly from day 0, these vibrations have 
reduced in activity by day 3 and instead an increase in activity of the out-of-
plane breathing ring of tyrosine is detected, 828 cm-1 2527. This characterisation 
goes in conjunction with a higher activity of stretching C-C bond from the 
skeleton of a polypeptide chain, reflected at 903 cm-1. Since contraction has 
occurred by day 3, it is reasonable to assume that crosslinking has reflected into 
a higher number of C-C skeletal vibration modes during the formation of α-helix 
structures and rearrangement of collagen fibres. Moreover, the notorious 
increase of out-of-plane vibration from tyrosine ring at day 3 could be an 
indication of the presence of LTQ cofactor located in the catalytical site of LOX 
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enzyme. The C=O group from LTQ binds to the e-NH from the lysine side 
chain, resulting in an aldehyde end product. Base on the MVA, the increase 
activity of tyrosine ring at day 3 of contraction could be indicative of higher 
activity from LTQ cofactor. 
 
 
Figure 29. A) PCA score plot of the amino acids region: According to the PCA 
analysis, spectral data from day 0 and day 3 are mostly separated by peaks at 
920 and 873 cm-1. B) PCA loadings of the amino acids region: PC-1 accounting 
for 73% of the variation, represented by positive values of 920 and 873 cm-1 
bands. PC-3, represented by positive values of 903 and 828 cm-1. These two 
peaks are considered the third component accounting for a variation of 4%.  
 
 
6.3.2 PAPILLARY LAYER 
While it may be true that the highest activity of contraction was seen from day 
0 to day 3, biochemical changes occurring over the course of three days did not 
manifested abruptly on day 3 for the papillary and reticular layers. Instead, 
qualitative Raman data showed that most biochemical changes occurring during  
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Figure 30. Raman characterisation of contraction in the papillary layer at 
different time points. Each time point is represented by their spectral profile. 
Each profile is an average of 60 spectra. In this figure, the most notorious 
differences between time points have been highlighted and expanded. These 
regions have been labelled as a) Amide III, and b) Amino acids & Nucleic Acids 
region. 
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contraction had expressed gradually throughout the four different time points. 
Most changes reported are reflected in terms of intensity. Figure 30 highlights 
spectral differences that are easy to identify by the naked eye, being Amide III 
and Amino acids regions the most notorious. 
 
To validate these observations, Raman statistical analysis –via MVA 
techniques– was performed on all spectral data to accurately spot the most 
relevant biomarkers. The main spectral differences highlighted by the PCA 
method were mostly consistent with the visual examination of the Raman 
qualitative data, which are described below. 
 
Amide III. At day 0, the following 
peaks appeared within the amide III 
region: 1341, and 1316 showing a 
lower intensity than the 1268/1245 
cm-1 doublet. Although the same 
peaks appeared after three days into 
contraction, they all reflected a 
reduced intensity when compared to the peaks presented in day 0. Now, 
according to the statistical analysis of the Amide III region, the PCA showed 
that at Day 0 of contraction, there was a higher activity from the peptidic bond 
belonging to the stretching vibration of C-N, 1244 cm-1, and bending vibration 
of the N-H, 1274 cm-1. Interestingly, by day 3 into contraction samples were 
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slightly scattered in the opposite quadrant as a result of a reduction in activity 
from the peptide bond, 1244 and 1274 cm-1, and instead characterised by a 
higher activity of the twisting vibration of CH3 and CH2 of collagen protein, 
1336 cm-1 Figure 31A. It is expected to assume that since composites had 
notoriously contracted by day 3, then collagen fibres have been crosslinking 
between one another. By then, LOX had already converted the e-amine from 
lysine residues into a highly reactive aldehyde. This will promote the 
interlocking between polypeptide chains that will eventually surround the 
peptide bond hindering the vibration of stretching C-N and bending N-H at the 
collagen backbone. 
 
Additionally to this, these lysine-derived aldehydes at the end of the side chains 
could be reacting with the N-H of the peptide bond from other polypeptide 
chains, resulting in the formation of a secondary amide bond. This reaction 
could also explain the reduction of the N-H bending vibration by day 3 into 
contraction. Furthermore, CH3 and CH2 are mostly located at the side chains of 
the collagen backbone. When crosslinking is occurring, it is due mostly to these 
side chains being linked to the side chains of other molecules. Crosslinking 
between lysine-derived aldehydes and remaining lysine residues will occur 
spontaneously as collagen fibres keep gliding over one another. This could be 
due to keratinocytes exerting contractile forces over the dermis during re-
epithelialisation. The aforementioned observation has been notorious from day 
0 to 3 Figure 31 and slightly noticed from day 3 to 7 Figure 32. 
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According to the PCA in Figure 32B, the separation between day 3 and day 7 
is mostly caused by PC-2, represented by the indirect correlation between 1244 
and 1336 cm-1. Correspondingly, this can also be seen in Figure 32C, where 
there is a significant difference between both peaks at day 3 (p<0.0001), 
whereas by day 7, peak 1336 almost reached intensity values for 1244 cm-1, still 
remaining significantly different (p<0.0003). At day 7 into contraction the 
stretching vibration of C-N from the peptide bond (1244 cm-1) keeps reducing 
in intensity over the course of time, whereas the twisting vibration of the CH2 
and CH3 bonds (1336 cm-1) keeps increasing. This could indicate that these 
bonds will be actively vibrating after the transformation of lysine residues into 
highly reactive aldehydes. However, the activity of the N-H bending vibration 
from the peptide bond has reached a plateau from day 3 to day 7. 
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Figure 31. A) PCA score plot of the amide III region: According to the PCA 
analysis, spectral data from day 0 and day 3 are mostly separated by peaks at 
1274 and 1244 cm-1. B) PCA loadings of the amide III region: PC-1 accounting 
for 88% of the variation, represented by positive values of 1274 and 1244 cm-1 
bands. PC-2, represented by a positive and negative value of 1242 and 1336 cm-
1, respectively. These two peaks are considered the second component with the 
next highest variation of 6%, showing an indirect correlation between peaks. C) 
Illustrates the vibration of chemical bonds characteristic of each time point. At 
day 0, the stretching of C-N is predominant, whereas day 3 is characterised 
instead by the twisting of CH2, CH3 bonds. 
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Figure 32. A) PCA score plot of the amide III region: According to the PCA 
analysis, spectral data from day 3 and day 7 are mostly separated by peaks at 
1334 and 1244 cm-1. B) PC-1 accounting for 85% of the variation, represented 
by positive value of 1273 cm-1 band. PC-2, represented by a negative and 
positive value of 1334 and 1244, respectively, with the next highest variation of 
7%, showing an indirect correlation. C) T-test analysis of the indirect 
correlation between 1243 and 1333 cm-1 bands. Mean and SD values were 
reported as [mean, SD]. For peak at 1243, values were [1.1931, 0.1659] for day 
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3 and [1.0431, 0.1559] for day 7. For peak at 1335, values were [0.8631, 0.1558] 
for day 3 and [.9295, 0.1799] for day 7. 
 
Amino and Nucleic Acids. In the 
amino acids region, the following 
peaks appeared during the starting 
point of contraction: 938, 920, 875, 
854, and 815 cm-1. By day 3, no 
significant shift in frequency was 
perceived, however, same peaks 
continue to appear at a lower intensity than in day 0. From day 3 to day 7 into 
contraction, a few differences were noticed. According to the PCA in Figure 
33A, at day 3 there is a higher activity of the stretching vibration of C-C bond 
from both, the hydroxyproline and proline ring, reflected at 854 cm-1 and 869 
cm-1 band respectively. However, by day 7, the activity of these vibrations was 
no longer as high as in day 3. Instead, day 7 was characterised by a higher 
activity of the stretching vibration of the C-C from the skeletal backbone of the 
collagen protein, 905 cm-1, and a significantly lower activity of both bands at 
854 (p<0.0001) and 869 cm-1 (p<0.0001). These changes in activity may be 
suggesting that upon cross-linking, the side chains of collagen fibres may be 
rearranging or compressing as a result of continuous interlocking between 
polypeptide chains. This reflects in less exposed side chains and higher activity 
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needed from the collagen backbone. Explaining the decrease of proline and 
hydroxyproline activity and increase of C-C backbone vibrations by day 7. 
 
 
Figure 33. A) Amino acids Region: PCA analysis, spectral data from day 3 and 
day 7 are mostly separated by peaks at 869 and 854 cm-1. B) PC-1 accounting 
for 56% of the variation, with positive values of 869 and 854 cm-1 bands 
showing a direct correlation. PC-2: positive values of 963 and 905 cm-1, with a 
variation of 4%. C) Spectral profile for day 3 in red and day 7 in green. D) T-
test analysis of the direct correlation between 869 and 854 cm-1 bands at day 3 
and day 7. Mean and SD values were reported, for peak at 869, values were 
[0.5826, 0.1139] for day 3 and [.4232, 0.0975] for day 7. For peak at 854, values 
were [0.7181, 0.1192] for day 3 and [0.5387, 0.1217] for day 7. 
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Figure 34. CA of Amide III region on Day 0 and Day 14 of contraction in a 
TEBM model. The unsupervised method clustered Day 0 and separate it from 
Day 14.   
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6.3.3 RETICULAR LAYER 
The analysis and interpretation of Raman data on the contraction occurring in 
the reticular layer of oral mucosa models are explained in this section. While it 
may be true that the highest activity of contraction was seen from day 0 to day 
3, biochemical changes occurring over the course of three days did not 
manifested abruptly on the spectra of day 3 for the reticular layer. Instead, 
qualitative Raman data showed that most biochemical changes occurring during 
contraction had expressed notoriously mainly between day 3 and 7. Most 
changes reported are reflected in terms of intensity. Figure 35 highlights 
spectral differences that are easy to identify, being Amide I, II and III the most 
notorious regions. 
 
To validate these observations, Raman statistical analysis –via MVA 
techniques– was performed on all spectral data to accurately spot the most 
relevant biomarkers. The main spectral differences highlighted by the PCA 
method were mostly consistent with the visual examination of the Raman 
qualitative data, which are described below. 
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Figure 35. Raman characterisation of contraction in the reticular layer at 
different time points. Each time point is represented by their spectral profile. 
Each profile is an average of 60 spectra. In this figure, the most notorious 
differences between time points have been highlighted and expanded. These 
regions have been labelled as followed, a) Amide I, b) Amide II, and c) Amide 
III region. 
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Amide I. At the starting point of 
contraction, the reticular layer 
reflected an amide I band at 1667 
together with a peak at 1605. By day 
3 of contraction, there was a lower 
amount of activity from the 
stretching vibration of the C=O bond 
from the α-helix conformation of 
collagen, 1657 cm-1. Together with this there was also a low activity in the 
stretching vibration of the C-C bond from phenylalanine and tyrosine residues, 
1606 and 1613 cm-1 respectively. By day 7 however, the activities of these bands 
increased considerably and were higher than at day 3. This translates in a higher 
intensity of bands at 1657, 1613 and 1606 cm-1. Tyrosine residue encompasses 
a variety of vibrational modes, which are reflected throughout the whole spectral 
range. For instance, the stretching mode of C-C from tyrosine reflects at 1613 
cm-1,131 whereas the bending mode of C-C appears at 1606 cm-1.23,70 As 
contraction increases, so does the activity of these bands reflecting a higher 
amount of tyrosine. Coupled with this, by day 7 most of the samples have shown 
a stronger tendency towards 1655 cm-1 indicative of C=O stretching vibration 
in an a-helix polypeptide chain. Based on the PCA analysis of Amide I region, 
the separation between both time points is mostly caused by the PC-4 loadings. 
As can be seen Figure 36B the PC-4 is accounting for 3% of the variation but 
it is significant enough to provoke a separation. 
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Figure 36. A) PCA score plot of the amide I region: According to the PCA 
analysis, spectral data from day 3 and day 7 are mainly separated by peaks at 
1655, 1613, and 1606 cm-1. B) PCA loadings of the amide I region: PC-1 
accounting for 75% of the variation, represented by positive values of 1657 and 
1603 cm-1 bands. PC-4, represented by positives values of 1655, 1613, and 1606 
cm-1. These three peaks are accounting for 3% of the variation showing a direct 
correlation. C) Schematic representation of the C=O group. D) The amide I 
region is expanded, spectral profile for day 3 in red and day 7 in green, with 
both peaks indicated by dotted line. E) T-test analysis of the direct correlation 
between all three bands from PC-4 at day 3 and day 7. Mean and SD values 
were reported as [mean, SD]. For peak at 1655, values were [1.2076, 0.1271] 
for day 3 and [1.3224, 0.1370] for day 7. For peak at 1613, values were [0.5153, 
0.1030] for day 3 and [.6603, 0.1239] for day 7. For peak at 1606, values were 
[0.5226, 0.1065] for day 3 and [0.6780, 0.1300] for day 7. 
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All three peaks have positive values, and since they are all under the same 
loading a positive correlation between all them is established. Correspondingly, 
in Figure 36E a t-test analysis of the intensities of all peaks between time points 
is shown. It can be seen how the difference between time points in all three 
peaks is considered significant, 1654 (p<0.0001), 1613 (p<0.0001) and 1606 
cm-1 (p<0.0001), indicating that as contraction increases, so does the intensity 
values of tyrosine (1606.34, 1613.09 cm-1) and the α-helix structure (1654.55 
cm-1). 
 
Amide II. According to the PCA of 
the Amide II region, a clear 
separation between time points 3 and 
7 was obtained mainly because of 
PC-2 and represented by band at 
1422 cm-1. Based on the loading 
shown in Figure 37, the 1446 cm-1 
band is responsible for PC-1. According to the PCA score plot, the bending 
mode of CH2 from proteins is equally active at both time points. Even after 
conversion of lysine residues into aldehydes, sporadic crosslinking to other 
lysine or available aldehydes will keep occurring. As a result, the non-enzymatic 
spontaneous crosslinking between aldehydes of different side chains will 
require the bending of the CH2 bonds. Reflecting similarly at both time points 
since contraction of the models keeps occurring. Additionally, at day 3 samples 
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reflected a higher activity of N-H in plane deformation than at day 7, which was 
manifested by a higher intensity of 1422 cm-1 band. However, since spontaneous 
crosslinking is still occurring by day 7, formation of secondary amides interrupts 
the vibration of this bond. This observation could be reflected as a reduction of 
the bending vibration of N-H from the peptide bond. 
 
 
Figure 37. PCA score plot of the amide II region: According to the PCA 
analysis, spectral data from day 3 and day 7 are mostly separated by PC-1 and 
PC-2. PCA loadings of the amide II region: PC-1 accounting for 82% of the 
variation, represented by a positive value of 1446 cm-1 band. PC-2, represented 
by a negative value of 1422 cm-1. This peak is considered the second component 
with 10% of the variation. 
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Amide III. At day 0, the following 
peaks were found in amide III 
region: 1341 and 1316 with a 
notoriously low intensity when 
compared to the 1268/1246 cm-1 
doublet. After day 3 into contraction 
not much spectral change was 
shown, only a slight decrease in intensity for all peaks previously mentioned. 
However, by day 7 both peaks at 1340 and 1317 considerably raise in intensity 
almost reaching the intensity values of the 1271/1251 doublet. According to the 
PCA done between day 3 and day 7, separation of both groups is caused mainly 
by PC-2, which according to the loadings it is represented by two peaks that are 
indirectly correlated, 1243 and 1335 cm-1. At day 3 of contraction, a higher 
activity of the stretching vibration of the C-N from the peptide bond was 
exhibited, 1243 cm-1. By day 7, this vibration slowed down in activity whereas 
the twisting vibration of CH3 and CH2 increased notoriously, 1335 cm-1. This 
observation confirms what was noticed in the epithelium and papillary layer, 
where the stretching vibration of C-N reduces in activity as crosslinking 
increases. As previously mentioned, this could be due to the limited flexibility 
remained after formation of secondary amines through the N-H from the peptide 
bond. Also, since polypeptide chains keep crosslinking between one another, 
rearrangement of collagen fibres kept occurring. Hence, it may be possible that  
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Figure 38. A) PCA score plot of the amide III region: According to the PCA 
analysis, spectral data from day 3 and day 7 are mostly separated by peaks at 
1335 and 1243 cm-1. B) PCA loadings of the amide III region: PC-1 accounting 
for 78% of the variation, represented by positive value of 1245 cm-1 band. PC-
2, represented by a negative and positive value of 1335 and 1243 cm-1, 
respectively. These two peaks are considered the second component with the 
next highest variation of 14%, showing an indirect correlation. C) T-test 
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analysis of the indirect correlation between 1243 and 1335 cm-1 bands. At day 
3 of contraction, intensity values are significantly different between the 
indirectly correlated bands (p<0.0001). By day 7, still there is a significant 
difference (p<0.0072), however the band at 1335 almost reached the 1243 cm-1 
intensity values. Mean and SD values were reported as [mean, SD]. For peak at 
1243, values were [1.2723, 0.1997] for day 3 and [1.0552, 0.1593] for day 7. 
For peak at 1335, values were [0.7640, 0.1431] for day 3 and [.9668, 0.1932] 
for day 7. 
 
the increase in twisting vibration from the CH3 and CH2 could be a result of the 
existing side chains compressing by the accommodation of fibres. In addition to 
this, by day 7 onwards, an upshift in frequency was detected from 1246 at day 
3 to 1251 cm-1 at day 7. 
 
6.4 SUMMARY 
 
Raman spectroscopy was successful in identifying the biochemical effects of 
contraction on TEBM models. The ability of this technique to monitor the 
process of contraction is proven by a number of biomarkers identified in this 
chapter. While it may be true that the role of LOX in contraction is well-
explained in the literature, RS is providing information regarding the regional 
effects of contraction that contributes in understanding the focal points of 
progression.  
1. For instance, it is described in this chapter the crucial role of the peptidic bond 
of collagen polypeptide chains (reflected in the Amide III region) as a biomarker 
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of crosslinking of collagen. As contraction increases as a function of time, so 
does the intensity band at 1336 cm-1, while the intensity of 1244 cm-1 decreases. 
This turnover of intensities became more drastically noticed during the highest 
activity of contraction.  
2. Moreover, RS also confirmed that biochemical changes of contraction are 
first manifested by the epithelium layer and as time goes by then it significantly 
appears in the papillary and reticular layer. The notorious spectral changes that 
each layer displayed at subsequent time points is an indication that contraction 
is moving in what it would be called a cascade effect.  
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7 CONTRACTION IN A TEBM MODEL WITH b-APN 
 
A substantial amount of research has been carried out to study the mechanism 
of contraction in tissue-engineered skin113,159-160 and oral mucosa models.119,120 
It has been well-established a direct correlation between an overexpression of 
lysyl oxidase (LOX) enzyme and the degree of contraction seen in these 
engineered models.161,162 Because of this, inhibition of LOX enzyme became 
the appropriate target in order to reduce the mechanism of contraction. Although 
studies then reported on a variety of pharmacologic approaches that prevented 
this phenomenon, most of them lead to unwanted secondary effects that render 
them counterproductive.113 The effect of β-APN on engineered models has been 
studied since and it has been well-documented that this drug is capable of 
preventing contraction to some extent by inhibiting the activity of LOX 
enzyme.113,162-163 Although considerable research has been committed to 
pharmacologic modulation of oral mucosa contraction, less attention has been 
paid to the need for a better understanding behind the mechanism of drug-3D 
composites’ interaction. For that reason, this chapter reports on the results 
obtained from characterising the inhibition of contraction in β-APN-containing 
TEBM models, with Raman spectroscopy.  
 
7.1 RESULTS & DISCUSSION 
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7.1.1 DIMENSIONAL ANALYSIS 
To quantify the degree of contraction occurring in β-APN-containing TEBM 
models, surface area of all samples was measured at different time points over 
a period of 14 days. Consistent with the previous experiment, the marking time 
points were day 0, 3, 7 and 14 at an ALI. All samples were photographed once 
a time point was reached and samples representing the time point in question 
were then removed from the six-well plate and fixed to be further processed and 
analysed. From the images obtained, the remaining surface area was then 
measured using Image J™ software, Figure 39. 
 
The extent of contraction was calculated at each time point and in Figure 40 a 
representation of the remaining surface area as a function of time can be seen. 
The average and SD values for each time point was calculated and listed below 
in Table 12. After three days at the ALI, the 3D composites only reduced to 
~10% of their surface area. In this case, the highest activity of contraction 
appeared to be between day 3 and day 7, where a reduction of ~23% of the 
surface area can be observed while from day 7 to day 14 only ~10% was lost. 
According to the data, the introduction of β-APN in the TEBM models seem to 
be reducing the progression of contraction.   
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Figure 39: β-APN-containing TEBM model. Sample #4 showing the extent of 
contraction at day 0, 3, 7 and 14. This sample was assigned as day 14 and 
photographed at each time point. Once day 14 was reached, sample was 
removed from the 6-well plate and fixed to be further analysed. 
 
Table 12. Average and SD values for the remaining surface area calculated at 
each time point in a β-APN-containing TEBM model. 
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0 0.894 (n=12) 0.21 100
3 0.804 (n=9) 0.14 90
7 0.596 (n=6) 0.06 67
14 0.509 (n=3) 0.05 57
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This can be related to Arnold et al. who reported that long-lasting effects of β-
APN is due to administration of periodic doses.164 Since in this experiment 
medium was replaced every 2-3 days with β-APN-containing medium 
(200µg/mL β-APN) contraction in TEBM models was periodically modulated 
 
 
 
 
Figure 40. Remaining surface area as a function of time in β-APN-containing 
TEBM models. Solid orange line is representing the average calculated for each 
timepoint. Dashed orange lines are indicating SD values. (One-way t test was 
performed: p<0.0214, *, for control model (blue).  P<0.0441,*, for drug model 
(orange)) 
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Figure 41. Unpaired t-test statistical analysis of surface area of control vs drug 
model as a function of time. Day 0 (p value .2385, ns). Day 3 (p<0.0001, ****). 
Day 7 (p<0.0001,****). Day 14 (p<0.0023, **). 
 
 
7.1.2 HISTOLOGICAL ANALYSIS 
In Figure 42 it can be seen the histological representation of β-APN-containing 
TEBM models at different time points during contraction. While at day 0 and 
day 3 a decent stratification of the epithelium was appreciated, this was not the 
case for day 7 and day 14, where a lack of vertical migration from the 
keratinocytes resulted in a poorly stratified epithelium. According to the 
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literature, introduction of β-APN into 3D composites hinders the differentiation 
of keratinocytes and fibroblast resulting in a direct effect on the stratification of 
the epithelium.165 
 
 
Figure 42. Histological images of β-APN-containing TEBM models at different 
time points. 
 
7.1.3 RAMAN SPECTROSCOPY CHARACTERISATION 
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To keep consistency between experiments, same procedure described in section 
5.4 was followed when analysing TEBM/β-APN with Raman Spectroscopy. 
Subsequently, data collected for both TEBM and TEBM/β-APN was then 
compared in order to establish the main differences and effects caused after the 
incorporation of β-APN drug. The epithelium, papillary and reticular layer were 
the three main layers that were studied. The purpose of this was to establish and 
compare the spectral profiles and detecting the differences occurring between 
each day of contraction.   
 
7.1.3.1 EPITHELIUM LAYER 
 
After incorporation of β-APN drug into the TEBM models, significant 
differences were noted in a delayed manner, especially when compared to the 
control data. Illustrated In Figure 43 the spectral profile of TEBM/β-APN 
models at different time points of contraction. As can be seen, spectral 
differences are not as noticeable as in the control data. Some of the spectral 
differences are noticed until day 7, which as it has been previously mentioned, 
day 7 was the highest activity of contraction in this group. It has been 
highlighted and expanded the regions that are more relevant and had higher 
spectral differences between time points in this layer. In this case and after 
analysis with MVA techniques, it became apparent that lipids molecules had a 
bigger role in the epithelial layer of TEBM/β-APN models. 
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Figure 43. Raman characterisation of contraction in a TEBM/β-APN models in 
the epithelium layer at different time points. Each time point is represented by 
their spectral profile. Each profile is an average of 60 spectra. In this figure, the 
most notorious differences between time points have been highlighted and 
expanded. These regions have been labelled as followed, a) Lipids and b) Amide 
II regions. 
 
When analysing the epithelial layer, the main spectral differences identified 
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lipids molecules. It has been previously reported that changes in cellular 
processes due to different types of diseases most often results in an alteration of 
lipids metabolism.166 In this instance, we evaluated spectral differences that 
were reflected after the incorporation of β-APN drug into the TEBM models. 
Since these differences were coming from lipid molecules, the possibility of 
lipids metabolism being compromised was explained in this section. Either 
lipids are being used as structural components of biological membranes of 
keratinocytes’ cells, or most likely, they are being used as the main source of 
energy storage to further be used for crosslinking of fibres. This theory was 
proposed since it has been reported that LOX enzyme has been directly 
correlated with increasing content of lipids in adipocyte tissue.167,168 Therefore, 
this section reports on the changes seen with regards to lipids molecules in the 
highest activities of contraction for both the TEBM and TEBM/β-APN data.  
 
The PC analysis performed on the Amide II region (1510-1390 cm-1) 
highlighted spectral differences responsible for a moderate separation between 
TEBM and TEBM/β-APN data. Accountable for this separation is the 
combination of PC-1 and PC-2 loadings. According to the score plot in Figure 
44A, at day 3 of contraction, there is a lower content of CH2 bending vibrations 
from fatty acids and lipids in the TEBM group that is being represented by the 
1440 and 1452 cm-1 respectively.169,170 This is not the case for the TEBM/β-
APN group. After incorporation of β-APN into the TEBM constructs, it is 
noticeable that the content of lipids is considerably higher by an up regulation 
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of the CH2 bending vibrations from both fatty acids (1440 cm-1) and lipids (1452 
cm-1). This observation is also seen when analysing the lipids region (3100-2680 
cm-1) in Figure 44B. Again, a higher content of lipids is found in the TEBM/β-
APN data than when compared to the control TEBM group. Overall, there is a 
higher asymmetric stretching vibration of CH2 bonds coming from lipids and 
fatty acids reflected in this case at 2881 cm-1. At day 7 however, this is no longer 
the case. When analysing the 1510-1390 cm-1 spectral region, lipids content 
appeared lower in the TEBM/β-APN group than when compared to the control 
data. Separation of both groups in Figure 45 is mainly caused by a decreased in 
the CH vibrations of lipids reflected at 1449 and 1465 cm-1. 
 
It has been reported that LOX enzyme has found to be directly correlated to the 
accumulation of lipids content in the adipose tissue during the pathological 
processes of obesity and cancer progression and metastasis.171,172 According to 
Huang et al., the enzyme plays a role in promoting the commitment of stem cells 
towards adipocyte lineage.167 It has also been documented that during the 
carcinogenesis process, LOX enzyme activity increases and so does 
disturbances in some aspects of lipid metabolism. This might be suggesting that 
overexpression of LOX enzyme may result in accumulation of lipid content 
during the initial stage of contraction. However, not all lipid storage seen in 
Raman is reflecting the anatomical components of biological membranes. The 
results highlighted above when comparing TEBM with TEBM/ß/APN data, 
might be indicating increase of lipid’s uptake as the main source of energy 
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during the contraction process. While it may be true that different type of 
tumours have shown glucose intake to be their main source of energy,173 others 
like prostate cancer have proven low intake of glucose and instead high 
dependence on lipid oxidation for energy purposes.172 In this case, lower content 
of lipids seen at day 3 in the TEBM group when compared to the TEBM/β-APN 
data could be indicating higher rate of lipid utilization during the highest activity 
of contraction. According to Figure 44C, surface area of TEBM models 
contracted ~48% in average, whereas in the TEBM/β-APN models only a 
reduction of ~10% was seen at day 3. This could be suggesting that content of 
lipids is first being accumulated during early stages of LOX activity, and then 
it is reduced during highest activity of contraction as it is being used as the main 
source of energy. Interestingly, at day 7 of contraction, the lowest content of 
lipids is now seen in the β-APN model. The highest activity of contraction after 
incorporation of β-APN drug was seen at day 7 with a reduction of ~23% in 
surface area. In comparison, the control models only reduced ~15% of surface 
area from day 3 to 7. This goes in agreement with the theory proposed above 
where higher activity of contraction translates into higher uptake of lipids 
utilisation as energy source resulting into lower content of lipids in the Raman 
data.  
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Figure 44: A) PCA score plot (left) and loadings (right) of the 1510-1390 
spectral region. According to the PCA analysis of day 3, spectral data from 
TEBM models is mostly separated from TEBM/β-APN group by PC-1 and PC-
2 loadings. Accounting for 84% of variation in the 1452 cm-1 band and 8% in 
the 1440 cm-1 band. B) PCA score plot (left) and loadings (right) of the 3100-
2700 spectral region. Responsible for the separation between groups, 69% of 
the variation was found in the 2881 cm-1 band for PC-1, whereas 17% was 
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shared between 2881 and 2916 cm-1 bands for PC-2. C) Unpaired t-test analysis 
of 1452, 1440, and 2881 cm-1 intensity bands for control and drug group (left) 
and an approximation of the amount of contraction from day 0 to day 3 seen in 
both groups. These analyses showed that the content of lipids reflected on those 
three bands is significantly higher (p<0.0001) for the TEBM/β-APN data, with 
~10% reduction in surface area, when compared to the control group, with 
~48% reduction of surface area.  
 
 
Figure 45. A) PCA score plot (left) and loadings (right) of the 1510-1390 
spectral region. According to the PCA analysis of day 7, spectral data from 
TEBM models is mostly separated from TEBM/β-APN group by PC-1 and PC-
3 loadings. Accounting for 82% of variation in the 1465 and 1449 cm-1 bands, 
and 4% in the 1477 cm-1 band. B) Unpaired t-test analysis of 1465 cm-1 intensity 
band for control and drug group (left) and an approximation of the amount of 
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contraction from day 3 to day 7 in both groups. These analyses showed that the 
content of lipids reflected on day 7 is lower in the TEBM/β-APN model, with 
~23% reduction in surface area, when compared to the control group, with only 
~15% reduction of surface area (p <0.0118).  
 
7.1.3.2 PAPILLARY AND RETICULAR LAYER 
Since 80% of the dermis is mainly composed by collagen type I, it is expected 
to see highly similar results in both the papillary and reticular layer. 
Nevertheless, both layers were analysed separately and only after comparing 
results it was noticeable that the effects shown in both layers were highly similar 
with, in some cases, only a delayed effect in timepoints. This resulted in the 
cascade effect and therefore it was decided to report together the conformational 
changes seen in collagen molecule after the incorporation of β-APN drug. This 
section reports on the conformational changes detected mainly in the secondary 
structure of proteins, together with the reaction of pivotal amino acids 
considered as biomarkers for the presence of collage molecule. In the previous 
chapter it was reported how contraction in a TEBM model produced 
biochemical changes that can be easily identified by day 3 with Raman 
Spectroscopy. However, after the incorporation of β-APN, changes in collagen 
molecule became less noticeable and therefore, more difficult to identify. The 
MVA technique was capable of identifying subtler differences in Amide I, 
Amide III and Amino acid spectral regions. 
 
Biochemical changes reflected in secondary structure of collagen. 
 RESULTS & DISCUSSION.  
Characterising Contraction in a TEBM/β-
APN Model With Raman Spectroscopy 
 
 144 
When analysing the effect of β-APN in a TEBM graft, differences in the 
secondary structure of collagen molecule were noted when compared to our 
control model. For instance, the PCA performed in the Amide I region (1800-
1510 cm-1) highlighted the spectral differences responsible for a separation 
between the TEBM and the TEBM/β-APN data. 
 
Accountable for this separation is the combination of PC-1 and PC-2 loadings. 
According to the score plot in Figure 46A, TEBM models after 3 days of 
contraction showed a higher content of α-helix secondary structure, together 
with phenylalanine and tyrosine residues. This observation was also noticed 
when comparing TEBM with TEBM/β-APN at day 7 Figure 46B and at day 14 
Figure 46C. The previous data goes in agreement with the data from Figure 
36, which shows that the content of α-helix and tyrosine residues increases as a 
function of time during contraction.  
 
However, the incorporation of β-APN to inhibit contraction in the TEBM grafts 
lead to different changes after 3 days of contraction. In contrast, TEBM/β-APN 
showed a higher content of C=O stretching vibrations from β-sheet and 
disordered structures, reflected at 1677 and 1664 cm-1 respectively. This goes 
in agreement with Robertson et al., who stated that collagen under the effect of  
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Figure 46. PCA score plot (left) and loadings (right) of the 1800-1510 cm-1 
spectral region in the papillary layer. A) PCA for day 3.  B) PCA for day 7.  C) 
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PCA for day 14. D) Unpaired t-test analysis of bands at 1657 and 1603 cm-1, 
since those were the main peak intensities responsible for a separation between 
groups. Differences in peak intensities between control and drug models are 
considered highly significant (p<0.0001). 
 
β-APN agent results in the distortion of α-helix chains rendering them unable to 
crosslink properly to other collagen fibres.174 These changes are also seen in the 
reticular layer of TEBM/β-APN models. Whereas according to Figure 46, the 
incorporation of β-APN has shown a reduction in the content of triple helical 
structure as well. Not only this, but the presence of disordered structures, 1672 
cm-1, only appears until day 14, whereas in the papillary layer this effect 
appeared since day 3. Since 80% of the dermis is composed by collagen type I 
fibres it is reasonable to assume that the effects that β-APN has on dermis will 
be seen in both papillary and reticular layer. Same biochemical changes seem 
to appear at different timepoints between layers, giving the appearance of the 
cascade effect where the effect is first seen in the papillary and then extended to 
the reticular layer. Additionally to this, a significantly lower content of tyrosine 
residue were detected in the TEBM/β-APN data when compared to the control 
group Figure 46 and Figure 47. Two possible theories can explain these results: 
(i) binding of β-APN drug to the active site of LOX enzyme, which contains 
tyrosine as part of the catalytic active site, could be inhibiting the vibration of 
this residue or (ii) the higher content of β-sheet structure keeps the amino acid 
side chains clustered and less exposed to vibration when samples are being 
analysed. It is well documented that residues such as tyrosine, phenylalanine 
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and tryptophan tend to form β-sheet secondary structures due to their bulky side 
chains.175 Compared to this, in the TEBM graft, the presence of in-plane 
bending vibration of tyrosine and phenylalanine reflected at 1603 might be an 
indication of the presence of LOX enzyme or rearrangement of the collagen 
fibres. As stated on the previous data, as contraction increases so does the 
content of α-helix secondary structure. In agreement with Floramonte et al.,175 
the biochemical structure of both alpha and beta secondary structures dictate the 
precise orientation of the amino acid side chains. Thus, in the case of α-helix 
structure, side chains are naturally exposed towards the outside of the central 
axe and hence more susceptible to vibrate than when compared to the ß-
secondary structure in the drug model.   
 
Furthermore, apart from showing lower than the average amount of tyrosine 
residues, according to Dukor et al.,176 the higher content of 1635 cm-1 band seen 
in the PCA for TEBM/β-APN at day 14, is representative of differences in 
collagen content Figure 46C. This goes in agreement with Chakrabarty et al. 
work,40 where it was reported that no degradation or synthesis of collagen fibrils 
was detected during contraction of soft-tissue grafts, but instead an increase in 
dermal mass measurement was noticeable with increasing contraction.40 It 
would be reasonable to suggest that the inhibition of LOX  
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Figure 47. PCA score plot (left) and loadings (right) of the 1800-1510 cm-1 
spectral region in the reticular layer. A) PCA for day 7. B) PCA for day 14. C) 
Unpaired t-test analysis of bands 1656 and ~1603 cm-1, since those were the 
main peak intensities responsible for a separation between groups. Differences 
in peak intensities between control and drug models are considered highly 
significant (p<0.0001).  
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activity by β-APN lead to the reduction of collagen crosslinking, hence resulting 
in a less compacted and fibrotic ECM and translating into less content of 
collagen fibres within the focal point of analysis. 
 
Amide III as a biomarker of collagen cross linking. 
As seen in the previous chapter, amide III reflected interesting information in 
the contraction of TEBM graft. It was established that the stretching vibration 
of C-N decreases (1245 cm-1) whereas the twisting vibration of CH3 increases 
(1335 cm-1) as a function of time during contraction. After introduction of β-
APN into the TEBM models, this biomarker was no longer noticeable. Instead 
it can be seen in Figure 48 the separation between control and drug data, where 
TEBM/β-APN at day 3 shows a higher content of 1244 cm-1, which according 
to Lakshimi et al., corresponds to the C-N stretching vibration from β-sheet and 
random coils structures.169 This goes in agreement with the higher content of β-
sheet and unordered structures (1677 cm-1 and 1664 cm-1) seen in Figure 47A 
when analysing the Amide I region. Together with this, TEBM/β-APN also 
showed a lower content than the average with respects to the twisting vibrations 
of CH3 and CH2 bands. This observation is also present at day 7 and day 14, 
where according to PC-2 loadings, TEBM/β-APN still shows a higher amount 
of C-N stretching together with a lower amount of twisting vibration from CH3 
and CH2 Figure 48B,C. As explained before, since β-APN is responsible for the 
inhibition of LOX activity, partial inhibition of collagen crosslinking has been 
achieved. This translates into less twisting and wagging vibration from the CH3 
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and CH2 groups located at the side chains of helical residues such as glycine and 
proline. If β-sheet has been the structure prevailing in the TEBM/β-APN data, 
it is reasonable to assume that due to the biochemical structure of this secondary 
structure, orientation side chains from Gly and Pro residues might be less 
exposed. This observation is also highlighted in the reticular layer when 
analysing the amide III region. A lower amount of CH2 and CH3 wagging 
vibrations from glycine and proline residues is seen in TEBM/β-APN group 
when compared to the control data. Together with this, a higher amount of C-N 
and N-H stretching vibrations from β-sheets and disordered structure is highly 
significant (p<0.0001) when compared to control data. Since the triple motif of 
Gly-Pro-Hypro is characteristic of the α-helical structure of collagen, it is 
reasonable to assume that treatment with β-APN resulted in the distortion and 
interruption of the triple helix structure and thus disruption of the Gly-Pro-
Hypro order. This resulted in a significant reduction of CH2 and CH3 vibration 
from side chains of these residues that is indirectly correlated to the increase in 
β-sheet structure.  
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Figure 48. PCA score plot (left) and loadings (right) of the 1390-1140 cm-1 
spectral region in the papillary layer. A) PCA for day 3. B) PCA for day 7. C) 
PCA for day 14. D) Unpaired t-test analysis of intensity bands ~1335 and ~1244 
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cm-1, since those were the main peak intensities responsible for a separation 
between groups. Differences in peak intensities between control and drug 
models are considered highly significant (p<0.0001) for all analyses, except for 
the 1243 cm-1 band at day 3 that showed a p<0.0024. 
 
 
Figure 49. CA of Amide III region on Day 7 of contraction on both, TEBM & 
TEBM/β-APN model.  When analysing the amide III region, the unsupervised 
method clustered the control data and separate it from the drug data, 
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complementing the results of the PCA.  Only few spectral points from the drug 
data clustered into the control group (*). 
 
 
 
Figure 50. PCA score plot (left) and loadings (right) of the 1390-1140 cm-1 
spectral region in the reticular layer. A) PCA for day 7. B) PCA for day 14. C) 
Unpaired t-test analysis of intensity bands at ~1336 and ~1244 cm-1, since those 
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were the main peak intensities responsible for a separation between groups. 
Differences in peak intensities between control and drug models are considered 
highly significant (p<0.0001) for all analyses, except for the 1243 cm-1 band at 
day 7 and day 14, which showed a p.value of 0.0017 and .0001 respectively. 
 
Relation between hydroxyproline residues and TEBM/β-APN Model 
When analysing the amino acids region (980 - 600 cm-1) with PCA, a separation 
between TEBM and TEBM/β-APN data becomes clear at day 3, 7 and 14. 
Coincidentally, responsible for this separation in all time points is PC-1 and PC-
3 loadings. According to the score plot and loadings in Figure 51, there is a 
higher content, in the TEBM/β-APN group, of C-C stretching vibration of 
proline ring and breathing ring of hydroxyproline residue, reflected at 855 cm-1 
[23,24]. Additionally to this, amino acid side chains from proline and 
hydroxyproline together with C-C stretching vibration of collagen backbone are 
reflected in higher content at 937 cm-1 band. According to Gullekson et al., the 
unique aromatic structure of proline’s side chain gives the amino acid a high 
conformational rigidity, directly affecting the bond formation with other amino 
acids and hence the nearest secondary structure to this residue.73 Thus, it is 
considered that the presence of proline residue usually results in the interruption 
of the nearest secondary structure from continuing with its usual orientation. 
Moreover, according to Qiu et al., variations in the content of hydroxyproline 
residue has been continuously used as an indicator of diseases caused by 
abnormalities in collagen metabolism.177 Treatment with β-APN agents inhibit 
crosslinking within and/or with other collagen fibres. This interruption often 
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leads to increasing content of what is known as soluble collagen. As stated by 
Robertson et al., excess of free hydroxyproline residues in the connective tissue 
might result in urinary disposal of the amino acid.174,178 In this case and in 
agreement with the previous statement, the higher amount of hydroxyproline 
residue found in both the papillary and reticular layer could be free 
hydroxyproline peptides ready to be disposed as a by-product of the disruption 
of α-helical structures. It has been well documented that treatment with β-APN 
goes together with increase content of urine hydroxyproline.179,180 This 
correlates with Keiser et al. findings, which state that higher amounts of soluble 
collagen after treatment with β-APN is accompanied by increased content of 
hydroxyproline in urine.181 The higher content of hydroxyproline ring vibration 
might be indicating that due to a lack of spontaneous crosslinking, collagen 
fibres might be having more flexibility to vibrate higher than when compared to 
the control data. β-APN is inhibiting the enzymatic conversion of telopeptide 
lysines and excessive crosslinking of telopeptide allysines to the α-helix 
structure, resulting in higher amount of soluble collagen and less fibrotic 
connective tissue.  
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Figure 51. PCA score plot (left) and loadings (right) of the 980-600 cm-1 
spectral region in the papillary layer. A) PCA for day 3. B) PCA for day 7. C) 
PCA for day 14. D) Unpaired t-test analysis of intensity bands at ~936 and ~855 
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cm-1, since those were the main peak intensities responsible for a separation 
between groups. Differences in peak intensities between control and drug 
models are considered highly significant (p<0.0001) for all time points. 
 
 
Figure 52. PCA score plot (left) and loadings (right) of the 980-600 cm-1 
spectral region in the reticular layer. A) PCA for day 7. B) PCA for day 14. C) 
Unpaired t-test analysis of ~936 and ~855cm-1 intensity bands, since those were 
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the main peak intensities responsible for a separation between groups. 
Differences in peak intensities between control and drug models are considered 
highly significant (p<0.0001) for all time points. 
 
7.2 SUMMARY 
 
Biochemical changes were successfully detected by Raman spectroscopic 
analysis despite the partial inhibition of contraction in TEBM models with β-
APN. RS and the use of MVA techniques identified main biomarkers involved 
in the inhibition of contraction due to the incorporation of β-APN. The 
characteristic rigidity of an overexpression of collagen crosslinking was 
disturbed with the incorporation of this drug, which lead to a higher occurrence 
of disordered β-sheet collagen fibres instead. Utilising lipids as the main source 
of energy, it can be concluded that with the incorporation of β-APN, the peptide 
bond (Amide III region) no longer contributed to the formation of triple helix 
structure, but instead lead to an unorganised rearrangement of collagen fibres. 
RS also highlighted the concentration of free hydroxyproline residues as a by-
product of the rearrangement of this secondary structure. This conclusion leads 
to the possibility of considering the peptidic bond (Amide III region) as a focal 
point for the progression of contraction, which independently upon the addition 
of β-APN, plays an active part in the formation of non-enzymatic crosslinks.  
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8 CONCLUSION AND FUTURE WORK  
 
Graft contraction continues to be a poorly understood clinical problem and a 
better insight into the underlying biochemical mechanism behind contraction is 
still very much needed. The use of Raman spectroscopy highlighted trends and 
biomarkers that can be considered as target points to tackle the routes of 
progression of graft contracture.  
 
This research established the peptidic bond (Amide III region) as a biomarker 
for monitoring the extent of contraction. Where overexpression of crosslinking 
occurred, so did the formation of α-helix conformation of keratin and collagen 
proteins. Where crosslinking was prevented through inhibition of LOX activity, 
the triple helix conformation of both proteins was disrupted and instead 
rearranged into unorganised and β-sheet conformation. This observation was 
first manifested in the peptidic bond of keratin polypeptide chains from the 
epithelium layer, and four days after in the peptidic bond of the collagen fibres 
from the papillary and reticular layer. Supporting the theory that contraction of 
oral mucosa and skin grafts is due to contractile forces of keratinocytes and 
expanding later on towards the rearrangement of collagen fibres. The above 
findings are of clinical relevance because it opens up the possibility of 
considering targeting the peptidic bond of both proteins (keratin and collagen), 
as the starting point, to prevent the cascade effect of the natural progression of 
contraction.   
	CONCLUSION & FUTURE WORK 
 
 
 160 
 
 
It would be interesting to carry these findings further and focus some research 
on: 
 
• Investigating this particular bond, and its potential to prevent the 
contractile forces of keratinocytes and the cascade effect of contraction, 
as a complementary measure to the inhibition of LOX activity by β-
APN. 
• The production of tissue-engineered normal skin models (TENS), 
which mimic as much as possible the in vivo human skin, before and 
after incorporation of β-APN drug. Utilizing different doses to analyse 
to what extent contraction can be inhibited. Raman analysis of 
contraction in these models at different time points and therefore 
interpretation of result. 
• Comparison of TEBM with TENS results would be a good study to 
corroborate even more the biomarkers and processes described in this 
thesis as part of contraction. Although both soft tissues are highly 
similar, it has been reported that TEBM models tend to contract slightly 
more than TENS models.  
• If available, apply the same experimental procedure with a different 
pharmacological agent for contraction modulation. For example, the use 
of D-Penicillamine would be an appropriate candidate to investigate. D-
Penicillamine is known to be an inhibitor of collagen cross-linking by 
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blocking lysyl-derived aldehydes through the formation of thiazolidine 
rings. Thereby, in theory, lysyl-derived aldehydes would no longer be 
able to easily cross-link with the amide group towards formation of a 
secondary amide. It would also inhibit the cross-linking between 
reactive derived-aldehydes.  It would be interesting to see the effects 
exhibited in the model after incorporation of D-Penicillamine, and to 
analyse the extent of contraction and inhibition of the crosslinking of 
the fibres.  
• These findings have highlighted another potential route for collagen 
cross-linking. From a broader perspective, it would be of value to test 
both theories of contraction (inhibition of lysyl oxidase, and inhibition 
of aldol condensation reactions) with the same experimental design, 
both in skin and oral mucosa models. Taking into consideration that 
each route is targeted through different pharmacological agents, it 
would be interesting to see if both drugs can be used together, in 
moderation, to test the effect they have on contraction.  
  
Finally, it has been concluded that Raman spectroscopy together with MVA 
techniques are highly capable of identifying differences and biomarkers without 
previous knowledge of the theory behind a physiological process. In this case, 
the results obtained from these studies corroborated and contributed to the 
literature available to date in terms of collagen crosslinking and the effect of the 
β-APN drug. It is interesting how Raman analysis of the data can highlight 
biomarkers that might be reflecting changes in the metabolism of specific 
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molecules. This technique shed light to metabolism of lipids and hydroxyproline 
that might be taking place as part of the contraction process of soft tissue 
engineered models.  
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9 APPENDIX 
 
9.1 GREENS MEDIUM COMPOSITION: 
- Dulbecco’s Modified Eagle’s Medium (DMEM) + Ham’s F-12 
Medium - In a 3:1 ratio respectively 
 
 
 
 
 
 Supplemented with:  
FCS 10% 50 ml 
Adenine 2 ml 
Glutamine 5 ml 
Fungizone 1.25 ml 
Penicillin + Streptomycin 5 ml 
Insulin 2.5 ml 
Hydrocortisone 80 $l 
EGF 2.5 ml 
Triiodothyramine (T/T) 500 $l 
Cholera Toxin 500 $l 
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9.2 FIBROBLAST’S MEDIUM COMPOSITION: 
 Dulbecco’s Modified Eagle’s Medium (DMEM)  
 
 
 
 
 
 
 
 
 
9.3 PREPARATION OF DED 
Before starting the procedure, make sure to arrange the following materials 
inside the LAF: 
 
1. Three universal tubes 
2. Universal rack 
3. IMS inside one of the universal tubes 
4. Two forceps 
5. One Scalpel with blade 
6. Waste container 
7. Petri dish with a bit of Green’s medium 
 Supplemented with:  
FCS 10% 50 ml 
Glutamine 5 ml 
Fungizone 1.25 ml 
Penicillin + Streptomycin 5 ml 
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8. Small ruler 
9. Marker container 
10. Allograft 
11. PBS 
12. 1 mol of NaCl 
 
When preparing allograft that has been stored in glycerol, the following 
instructions must be followed, 
 
1. Transfer allograft from glycerol into container “1” full of PBS.   
2. Keep allograft in incubator at 37 C for 24 hours. 
 
After 24 hours… 
 
3. Transfer allograft from PBS to a new container full of PBS. 
4. Repeat step 2. 
 
After 24 hours… 
 
5. Transfer allograft from PBS to a new container full of PBS. 
6. Repeat step 2 
 
After 24 hours… 
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7. Transfer allograft from PBS to a new container with 1mol NaCl 
8. Repeat step 2 
 
After 24 hours… 
 
9. With the ruler and a marker, trace a 2 cm2 square under the petri dish 
surface 
10. Place allograft insider the LAF and transfer it from the container into 
the petri dish. 
11. With the forceps, gently expand the whole allograft, making sure 
epidermis is facing upwards. 
12. Try to gently remove the epithelium from the dermis and place it aside 
were it would not be disturbed. 
13. If the epidermis comes out easily, proceed by cutting the dermis in 2 
cm2   by following the trace that has been previously drawn under the 
petri dish surface. 
14. Place each dermis sample in each six well plate, using a total of 3 six-
well pates. 
 
9.4 PASSAGING OF CELLS 
 
1. Remove the entire medium from the flask with a 15 mL pipette and 
discard it in a bleacher beaker. 
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2. Wash the cells with 10 mL of PBS. 
3. Remove all the PBS from the flask with a 15 mL pipette and discard it 
in the bleacher beaker. 
4. Add 5mL of Trypsin.  
5. Put the cells in a CO2 incubator for 5 minutes to make sure most of the 
cells have detached. 
6. After 5 minutes, remove the cells from the incubator and add 5 mL of 
medium (equal volume as with trypsin).  
7. With a 15 mL pipette, remove all the content from the flask and 
transfer it to a universal tube. 
8. Centrifuge at 1000 rpm/5 minutes with a bench top centrifuge. 
9. Carefully discard the supernatant in a bleacher beaker. 
10. Place the cell-pellet in a new flask with10 mL of culture medium. 
11. Incubate the flask for 2 or 3 days in the CO2 incubator 
12. After 2 or 3 days, look at the cells under a microscope and determine 
whether or not they have reached 80% confluence, and if they have, 
repeat the process from 1 to 12. 
13. If they have reach 80% confluence, proceed to do cell counting with 
trypan blue and then seed on DED 
 
 
9.5 FREEZING CELLS 
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Before starting the procedure, make sure to arrange the following materials inside the 
LAF: 
 
1. Fibroblast Medium 
2. Pipette boy 
3. 10 mL pipettes 
4. Waste container 
5. Universal tubes 
6. Universal rack 
7. DMSO 
8. Cryovials 
9. Cryovials rack 
10. New T75 flask 
11. Fibroblast flask 
 
To froze cells, follow the protocol below: 
 
1. With the 10 mL pipette, transfer Fibroblast Medium from the T75 flask to the 
waste container (avoid touching the T75 surface where cells are attached). 
2. With a new 10 mL pipette, transfer 6 mL of PBS from the PBS container to the 
T75 flask.  Rinse the surface of the flask for 10 seconds and proceed by 
discarding the PBS into the waste container (always using a new 10 mL 
pipette). 
3. Transfer 5 mL of trypsin aliquot into the T75 flask and incubate it at 37 C for 
5 minutes. 
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After 5 minutes… 
 
4. Place the T75 flask inside the LAF and with a 10 mL pipette transfer the trypsin 
solution to a universal tube.  To neutralise trypsin activity, add 10 mL of 
Fibroblast Medium into the universal tube and resuspend four times. 
5. Centrifuge the universal tube at 1000 rpm/5 min. 
 
After 5 minutes… 
 
6. Place the universal tube inside the LAF and carefully discard the supernatant 
into the waste container without disturbing the cell pellet.   
7. Close the universal tube and tap it against the LAF to resuspend the break down 
the cell pellet. 
8. Add 4 mL of Fibroblast medium into the universal tube and resuspend to create 
a homogenous cell suspension. 
9. From the universal tube, transfer 1 mL of cell suspension into a new T75 flask 
and label it accordingly. 
10. Add 11 mL of Fibroblast medium into the new T75 flask to complete the 12 
mL cell suspension. 
11. Store the new T75 flask in the incubator at 37 °C. 
12. Centrifuge again the remaining 3 mL of cell suspension at 1000 rpm/5 min. 
13. Repeat step 6 
14. Repeat step 7 
15. Add 3 mL of FCS into the universal tube and resuspend to create a homogenous 
cell suspension. 
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Before freezing your cells, it is important to do cell counting and find out how 
dense your cell suspension will be.  To achieve this, follow the procedure 
below: 
 
16.  With a micropipette, transfer both, 10 ul of cell suspension and 10 ul of trypan 
blue into a cryovial.  Resuspend it and place 10 ul into the haemocytometer. 
17. Proceed with cell counting 
       
      After cell counting… 
 
18. With a micropipette, transfer 900 ul of cell suspensions from the universal tube 
into each cryovial. 
19.  With a new micropipette, transfer 100 ul of DMSO from the DMSO container 
into each of the previous cryovials. 
20. Close cryovials and quickly placed them inside the -80 C freezer. 
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Figure 53. PCA of Amide III region in the epithelium layer. All four time points 
were analysed in the same matrix resulting in the isolation of day 0 from day 3 
and from the rest of the groups. Responsible for this separation are peaks at 1245 
and 1339 cm-1.  
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Figure 54. PCA of Amide I region in the epithelium layer. All four time points 
were analysed in the same matrix resulting in the separation of day 0 from day 
3 and the rest of the groups. Responsible for this separation are peaks at 1605 
and 1613 cm-1. 
 
										APPENDIX  
																
 
 173 
 
Figure 55. PCA of Amino acids region in the epithelium layer. All four time 
points were analysed in the same matrix resulting in the separation of day 0 from 
day 3 and the rest of the groups. Responsible for this separation are peaks at 872 
and 920 cm-1. 
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Figure 56. PCA of Amide III region in the papillary layer. All four time points 
were analysed in the same matrix. In this layer, groups are slightly separated 
from each other, starting with day 0 in the bottom right quadrant and ending 
with day 14 in the opposite quadrant.   
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Figure 57. PCA of Amino acids region in the papillary layer. All four time 
points were analysed in the same matrix resulting in the separation of day 0 from 
day 3 and the rest of the groups.  
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Figure 58. PCA of Amide III region in the reticular layer. All four time points 
were analysed in the same matrix resulting in the separation of day 0 and day 3 
from day 7 and day 14 groups. In this layer, a more distinctive separation can 
be seen between day 3 and day 7. 
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Figure 59. PCA of Amino acids region in the reticular layer. All four time points 
were analysed in the same matrix resulting in the separation of day 0 from day 
3 and the rest of the groups. Responsible for this separation are peaks at 855 and 
939 cm-1. 
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Figure 60. CA of Amide III region on Day 3 of contraction in both TEBM & 
TEBM/β-APN groups.  When analysing the amide III region, the unsupervised 
method clustered control data and separate it from drug group, complementing 
the results of the PCA.
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